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1.  Introduction 
1.1 General Introduction 
The immune system consists of specialized cells that settle in the periphery of the body or in 
the lymphoid organs. They are capable of discriminating between self versus non-self 
organisms. The cells that form the immune system are of haematopoietic origin. The 
respective precursor cells can be found in the bone marrow in adult mammals. The immune 
system is divided into an innate and an adaptive component [1]. Within both of these systems, 
there are specialized cells that communicate via direct interaction of surface molecules and 
through the distribution of messengers (e.g., cytokines) [2-4]. “Cytokine” is a collective term 
for peptide molecules with regulatory effects secreted by cells. Thus, this term comprises a 
heterogeneous group of molecules [5].  
The innate immune system is characterized by the rapidity in the response to danger signals. 
Innate mechanism of self defense were acquired by vertebrates long before the evolution of an 
adaptive immune system. Even single-cell organisms have heritable defense mechanisms, and 
every multicellular organism appears to have a complex innate immune system [6]. The basic 
protective strategy of an innate immune system is for the organism to constitutively produce 
generic receptors that recognize conserved patterns on different classes of pathogens to trigger 
an inflammatory response that limits pathogen invasion [7-9]. By contrast, specific adaptive 
immunity depends upon the somatic diversification of antigen-receptor genes to generate vast 
repertoire of cells, each of which expresses a different antigen receptor. Lymphocytes, the 
specialized cell type of adaptive immunity, use their cell-surface receptors to recognize 
antigenic configuration of specific pathogens. The response to antigen triggering consists of 
clonal amplification, cellular differentiation, and production of antibodies with the same 
antigen binding specificity [10]. The adaptive immune response is usually more effective, but 
it requires a certain amount of time to be initiated. However, T- and B-cells can differentiate 
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into memory cells that enable a faster specific immune answer in case of repeated contact 
with the pathogen.  
Among the most important cells in the innate immune system are phagocytic cells such as 
neutrophils, granulocytes, and macrophages [7]. These cells identify pathogenic agents by 
means of rather general and recurrent structures, for example on their surface (so-called 
PAMPS = pathogen associated molecular patterns) [9]. They then phagocyte the pathogens 
and secrete messengers, which in turn attract and activate further immune cells. This part of 
the immune system can be activated rapidly and thereby forms a primary defense line.  
The bactericidal action is made possible by several means, such as the production of reactive 
oxygen species (ROS) [11]. The synthesis of ROS is a physiological event, as several 
metabolic processes lead to the release of reactive intermediates as by-products of their 
reactions [12]. Besides being extremely harmful for the pathogen, these reactive molecules 
are also dangerous for the host cells. This is the reason why numerous enzymes are involved 
in their detoxification [13].  
Signal molecules play a crucial part in the regulation of the immune defense. Cytokines and 
chemokines are synthesized and secreted by many cell types upon contact with a pathogen. 
They can increase cell activity autocrinously in a positive feedback, or they can activate 
surrounding cells paracrinously. Chemokines mainly attract further immune cells, whereas 
cytokines have a number of rather diverse effects. Among other functions, they can stimulate 
or inhibit cell proliferation, or act as differentiating factors for certain cell types [14].  
Like all signal molecules, they bind to specific receptors on the target cell. This in turn 
activates a signal cascade that will cause a change in transcriptional activity of the cell. The 
gene transcription is regulated by the interaction of transcription factors, co-factors, specific 
binding sequences on the DNA, and the conformation of the DNA [15-17]. Not only the 
signals mediated by the cytokines, but also the signals mediated by the specific T- and B-cell 
receptors play an important part in the immune system. During development, the signals 
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mediated by these receptors are aimed at selecting cells with appropriate receptors [18]. Later 
on, the binding of the relevant antigen to the receptor, along with other co-factors such as 
cytokines, activates T- and B-cells and also in this process, the signals are translated into a 
change in gene regulation within the cell, thus they affect the activity of various transcription 
factors [19].  
 
1.2  The mouse as a model organism 
Research on the different components of the immune system and their regulation, as well as 
the mechanisms leading to a collapse of the immune system, would be hard to imagine 
without the mouse as a model organism.  
Sequencing of murine and human genome revealed that 95% of the coding sequence is 
conserved at the DNA level [20, 21]. Likewise, the immune system of the mouse shows a 
considerable similarity to the human immune system. Many human diseases can be found as 
well as induced in mice. Hence, at least part of the data derived from mice generalizes to 
immunological processes in humans. Moreover, mice are relatively easy to breed and keep.  
Various in-bred lines ensure reproducibility of the results because these mice (like clones) do 
not exhibit any genetic differences. The greatest advantage, however, concerns the possibility 
to induce systematic changes in the mouse genome and to examine their effects in vivo [22].  
When both alleles of a gene have been deactivated completely by a certain mutation, a knock-
out mouse has been bred. With such mouse mutants, it is possible to examine the phenotypic 
effects of a specific gene loss.  
Conditional mutants have proven of value in cases where the complete loss of a gene leads to 
a lethal defect, or to address special research questions [23, 24]. In these animals, the target 
gene or parts of it (e.g., an exon) is flanked in both alleles by two identification sequences for 
Cre recombinase (loxP sequences; lox = locus of crossing over). This is also called floxed 
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allele. By inserting the loxP sequences in non-coding parts of the gene, the latter remains 
intact and does not cause a phenotype. Only the expression of Cre recombinase within the 
same cell leads to the loss of the DNA section located between the loxP sequences, and thus 
to the inactivation of the respective gene. 
There are several mouse lines in which Cre is expressed under control of cell type-specific or 
inducible promoters, with either ubiquitous or tissue-specific induction. The advantage of 
conditional mutagenesis concerns the possibility to systematically knock out genes in specific 
cell types and study the effects. In the contest of immune system research, this approach 
offers the opportunity to identify the biologically relevant cells for certain processes. 
Examples include infection and autoimmunity research. 
 
1.3 Signal transduction in the immune system: Interleukin 12 (IL-12) and its 
cytokine family 
Interleukin is a historical term referring to signal molecules that serve the communication 
between leukocytes. This narrow definition is no longer valid because various interleukins 
also transfer signals to cells that do not belong to the haematopoietic system. Cytokines and 
their specific receptors are classified into different families according to structural similarities. 
The cytokine families are: haematopoietics, interferons, chemokines, and tumor necrosis 
factors. The cytokine receptors are distributed among the cytokine receptor family-1 or 
haematopoetin receptor-superfamily, cytokine receptor family-2 or interferon receptor-
superfamily, and the tumor necrosis factor receptors.  
Cytokines and chemokines form the basis for communication between cells involved in the 
immune defense. As described above, the immune system can be divided into the innate or 
unspecific immune defense and the adaptive or specific immune defense. For both parts, there 
are specialized cells as well as specialized cytokines that are characteristic of the immune 
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reaction. IL-12 belongs to the type 1 or pro-inflammatory cytokines that are characteristic of 
the innate immunity and promote the initiation of an inflammatory reaction [25].  
IL-12 is mainly produced by phagocytic cells such as macrophages and neutrophils, 
representing the first defense line against invading pathogens, as well as dendritic cells (DC), 
whose role is to present antigens and activate T-cells.  
The invasion of a pathogenic agent is primarily identified by the innate immune system. This 
involves phagocytic cells such as granulocytes and macrophages and the antigen-presenting 
dendritic cells. These cells then release IL-12 as one of the first cytokines [26, 27]. IL-12 is 
the first identified heterodimeric cytokine. It consists of two subunits p35 and p40 that are 
covalently bound.  
The DNA sequences of both subunits are located on different chromosomes both in mice and 
humans, and their expression is regulated independently of one another [28].  
The murine gene for p35 is located on chromosome 3 and contains 7 exons. The p40 gene is 
located on chromosome 11 and consists of 8 exons whose length is approximately 14 kb [27, 
29]. IL-12 is secreted only when both genes are transcribed in a cell. While the expression of 
p35 has been verified in a large variety of cell types, the expression of p40 is restricted to 
those cell types that can also secrete IL-12 [30, 31]. As opposed to the p35 subunit, the p40 
subunit can be secreted alone and forms homodimers in mice. These can interact with the 
receptor and thereby act as a competitive inhibitor [32, 33]. However, the biological function 
of homodimers is controversial [34-36].  
Sequence analyses yielded a close relationship between IL-12 and interleukin-6 (IL-6) . IL-6 
binds to its receptor as a homodimer, consisting of the IL-6R  chain and a gp130 chain. The 
gp130 chain serves as a signal transduction chain for various interleukin receptors. Moreover, 
there is a soluble form of IL-6R  that can also bind IL-6 and can associate with membrane-
bound gp130. In this manner, even those cells that do not express the IL6R  chain can 
become susceptible to IL-6.  
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IL-12 p35 shows a considerable homology to IL-6, whereas p40 is homologous to the IL-6R  
receptor chain. Both of the IL-12 receptor chains, IL-12R1 and IL12R2, are in turn 
homologous to gp130. This similarity prompts the conclusion that IL-12 has derived from an 
early form of IL-6 and its soluble receptor [37-39].  
The target cells of IL-12 are natural killer cells (NK-cells) and T-cells. The latter express the 
IL-12 receptor which comprises two subunits. Because of their homology to -type cytokine 
receptors, these subunits are classified as IL-12R 1 and IL-12R 2. In addition to GP130, this 
group of receptors includes the leukemia-inhibitory factor receptor (LIF receptor) [40]. 
In mice, the IL-12R 1 chain is mainly responsible for binding the ligand, while the 2 chain 
is involved in signal transduction [41, 42]. The binding of IL-12 to its receptor leads to an 
activation of the JAK-STAT signal cascade (JAnus Kinase and Signal Transducer and 
Activator of Transcription). Transphosphorylation of the receptor-associated kinases JAK2 
and Tyk2 leads to a prevailing binding of STAT4 molecules, which in turn are 
phosphorylated. In the nucleus, STAT4 homodimers can stimulate the transcription of target 
genes such as IFN  [43]. Moreover, IL-12 is involved in the differentiation and proliferation 
of Th1-cells [44, 45], the maturation of cytotoxic T-cells [46], and the proliferation and 
activation of NK-cells [47, 48].  
Even though IL-12 was originally discovered because of its stimulating effect on the 
cytotoxicity of NK-cells [26], the most important function of IL-12 concerns the activation of 
the IFN  expression by T-cells and NK-cells [49]. Such an expression can induce and polarize 
the T-helper response towards the cell-mediated immune answer (Th1). The Th1 response 
refers to the reaction of the organism to primarily intra-cellular pathogens (e.g., mycobacteria) 
in which naïve CD4
+
 Th0 cells increasingly develop into TH1 cells, while at the same time 
inhibiting the development of Th2 cells. Th1 and Th2 cells mainly differ in the kinds of 
cytokines they produce. TH1 cells predominantly secrete IFN , Interleukin 2 (IL-2), and 
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tumor necrosis factor-  (TNF ), also termed “lymphotoxin” [50]. These cytokines have an 
activating effect on macrophages, NK-cells, and neutrophils, i.e. on the cellular components 
of the innate immunity. Moreover, the Th1 immune response is characterized by an activation 
of cytotoxic (CD8
+
) T-cells, as well as an expression of isotype IgG2a antibodies that can 
interact with the complement system. Recently, the Th1/Th2 paradigm has been 
revolutionized  by the discovery of new cytokines in the IL-12 family and of the utterly new 
IL-17 family.  
 
 
 
Figure 1: IL-12 family of cytokines. Members of the interleukin-12 (IL-12) family of cytokines comprise a 
helical subunit (blue ovals) and a receptor-likeβ-chain. IL-12p70 and IL-23 share a common chain (p40) and 
their receptors share the IL-12 receptor β1 (IL-12R β1) chain. Obtained from [51]. 
 
Th17 cells were proven to be the principal pathogenic effectors in several types of 
autoimmunity previously thought to be Th1-mediated. In 2000 a new member of the IL-12 
family was discovered, IL-23. IL-23 is composed of the p40 subunit (the same subunit of IL-
12), and the p19 subunit [52] (cf. Figure 1). The receptor consists of the IL-12R 1 chain and 
the IL-23R chain [53]. IL-23 shares part of its functions with IL-12, but there are several 
important differences. IL-23 is secreted mainly by activated DCs. As opposed to IL-12, it 
cannot stimulate the proliferation of naïve CD4
+
 T-cells. Moreover mice deficient in IL-23 
lose development of a population of an IL-17-expressing subset of CD4 T cells [54]. While 
IL-12 is the master regulator of the Th1 immune response, IL-23 is a key element in the 
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differentiation of Th0 cells to Th17, and this kind of immunity is particularly important for 
host protection against extracellular bacteria and some fungi. 
 
1.4  Phenotype of conventional knock-out mice for the IL-12 subunits p40 (p40-/-) and 
p35 (p35-/-) 
For both of the IL-12 subunits, knock-out mice were generated and analyzed [55-57]. The 
mice of both lines developed normally and showed no changes in organ development, 
haematopoiesis, or fertility. However, mice with mutations in the IL-12 gene are susceptible 
to intracellular pathogens such as Listeria monocytogenes(add ref), Taxoplasma gondii [58], 
Leishmania major [59], and various mycobacteria, including normally apathogenic strains 
[60]. 
IL-12 has been shown to play an essential part in the production of IFN  in reaction to 
intruding pathogens. However a small fraction of IFN  is produced independently of IL-12 
[55, 57]. The Th1 immune response of IL-12 p40-/- mice could not be restored completely by 
a treatment with recombinant IL-12 (rIL-12), which proves that a Th1 immune response 
requires both IFN  and IL-12 [55]. Contrary to expectations, differences between p35-/- mice 
and p40-/- mice have been found in a number of infection experiments. The p35-/- mice tend 
to be less vulnerable to pathogens or show a less severe etiopathology. These findings gave 
rise to speculations whether the p40 homodimers that can be formed in p35-/- mice play a role 
in this context [61]. However, the discovery of IL-23 showed that the inactivation of p40 
results in knocking out two interleukins at the same time. Since IL-12 and IL-23 share some 
functions, the differences between p35-/- mice and p40-/- mice are probably due to a lack of 
IL-23 in the latter, rather than the lack of p40 homodimers [62]. In any case, the biological 
relevance of the homodimers remains controversial and needs to be taken into account in a 
later analysis of mice with the conditional knock-out of the p40 gene. 
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1.5  Manganese Superoxide Dismutase 
Manganese Superoxide Dismutase (MnSOD, SOD2) is a mitochondrial antioxidant enzyme 
belonging to the SOD gene family. Its main function is to catalyze the dismutation of the 
superoxide anion into molecular oxygen and hydrogen peroxide [63]. The importance of this 
gene family is demonstrated by their presence in nearly all organisms. There are several forms 
of this protein in mammals: SOD1 (Cu-ZnSOD), SOD2 (MnSOD), and SOD3 (extracellular 
EC-SOD). SOD1 is abundant in the cytosol and in the intermembrane space of mitochondria 
[64]. In mitochondria, SOD1 has recently been shown to cooperate with cytochrome-c to 
trigger apoptosis upon leaking out into the cytosol [65]. SOD3 is an extracellular form and is 
constitutively expressed.  
MnSOD is a homotetramer containing one manganese atom in each subunit. Its gene is 
composed of 5 exons. Both the dimerization domain and the manganese-binding site are 
contained in the third exon. Inside the cell, SOD2 is located in the mitochondrial matrix, 
where it controls the cellular redox environment and regulates superoxide and hydrogen 
peroxide signaling [66]. Its distribution in the organs is directly proportional to energy 
consumption rates, thus it is expressed mainly in heart, brain, liver, and kidneys [67].  
In physiological conditions, the major role of MnSOD is to protect against the reactive 
oxygen species (ROS) generated in the mitochondria as a byproduct of electron transport and 
oxidative phosphorylation. In the absence of SOD2, there will be an accumulation of 
superoxide anions inside the mitochondria. This can impair mitochondrial functions by 
directly reacting with molecular targets or combining with nitric oxide and in turn be 
transformed in the highly reactive peroxinitrite or hydroxyl radical. SOD2 expression can be 
induced both by chemical stimuli (cytokines like IL-1β, TNF, IL-4, TNF-α and LPS) and by 
physical ones [68-72]. 
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Knock-outs of Sod1 and Sod3 have been generated and are viable. In contrast, Sod2 knock-
outs display a severe phenotype, with effects ranging from embryonic dilated cardiomyopathy 
and in utero death [73] to early post-natal death (day five after birth) due to hepatic steatosis, 
severe mitochondrial defects, and massive dilated cardiomyopathy [74, 75]  
Depending on the genetic background, the inactivation of the gene has been reported to have 
various effects ranging from neurodegeneration to cardiomyopathy, but in any case leading to 
death within 18 days after birth [76, 77].  
The SOD2
+/-
 mouse model has been widely used in pharmacological and toxicological studies 
as well as research on aging, cardiovascular diseases, and neurodegenerative disorders [78-
82]. However, to date no direct involvement in infectious diseases has been investigated 
because of the considerably short life-span of the available murine models. To circumvent this 
problem, we used the Cre-loxP system to generate a conditional knock-out mouse line, in 
which the gene inactivation takes place only in macrophages and neutrophils [83]. The first 
line of defense against invading pathogens is represented by phagocytes of the innate immune 
system. Subsequent to phagocytosis, the NADPH oxidase complex is assembled [84], and a 
massive amount of ROS is produced which is critical for the bactericidal action [85]. A 
hallmark of this event is the transient abnormal uptake of oxygen, the so-called respiratory 
burst.  
SOD2 is localized in the mitochondria, an organelle whose high sensitivity to oxidative stress 
and key role in intrinsic apoptosis pathway have been demonstrated widely [86-88]. 
Moreover, it has been observed that SOD2 is up-regulated following infection with Group A 
Streptococcus [89]. These findings suggest that SOD2 is involved in detoxifying the highly 
dangerous oxygen radicals produced to challenge the infection.  
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1.6  Streptococcus pyogenes 
Streptococcus pyogenes is an extracellular Gram+ pathogen responsible for a broad spectrum 
of diseases, including mild infections of the skin and the upper respiratory tract, bacteremia, 
and in most severe cases necrotizing fasciitis, sepsis, and septic shock.[90, 91]. It is classified 
as Group A Streptococcus (GAS) because of the induction of β-hemolysis on blood agar. 
Virulence factors such as lipoteichoic acid enable bacterial invasion of epithelial tissues [92]. 
The hyaluronic acid capsule has been shown to prevent phagocytosis [93], while M-protein 
confers resistance to phagocytosis by inhibiting activation of the alternative complement 
pathway [94]. Resident macrophages play a key role in controlling GAS infections[95, 96]. 
They recognize, phagocyte, and destroy bacteria. Moreover, they produce cytokines and 
chemokines that are crucial in controlling the recruitment and activation of inflammatory 
cells, mainly PMNs, at the site of infection [95, 96]. It is generally assumed that the activation 
of macrophages is directed toward the elimination of the invading pathogen. However it can 
also be the case that an excessive and unregulated stimulation may lead to a continuous 
release of pro-inflammatory mediators, whose synergy can possibly result in septic shock 
[97]. In the present study, the KTL-3 strain of Streptococcus pyogenes was employed in 
subcutaneous infection models. The GAS KTL-3 strain, also referred to as flesh-eating 
bacteria, was first isolated from the blood of a patient with streptococcal bacteremia [98]. The 
ability of such bacterial strain to escape host defenses and invading soft tissues raised interest 
about these particularly aggressive bacteria. In susceptible mouse strains, bacteria injected 
subcutaneously were found in the blood three days after infection, and these mice eventually 
died of septic shock [99].  S. pyogenes-induced macrophage activation results in the up-
regulation of several pro-inflammatory and bactericidal factors[89]. Interestingly, MnSOD 
gene transcription levels were four-fold higher than in uninfected macrophages. Hence, 
investigating the role of MnSOD in streptococcal infections may shed light on this unexpected 
phenotype observed during in-vitro experiments.  
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1.7  Staphylococcus aureus 
Staphylococcus aureus (S. aureus) is an extracellular Gram+ pathogen capable of causing a 
diverse spectrum of diseases such as cutaneous and invasive infections [100]. It can colonize 
the skin and mucosal surfaces in an asymptomatic manner. Moreover, in severe invasive 
infections, it can lead to sepsis, pneumonia, and endocarditis [101]. The emergence of the 
multi-drug resistant S. aureus has become a major public health concern [102, 103]. While the 
reason for susceptibility to S. aureus remains unknown, there is increasing evidence that aside 
from bacterial pathogenicity factors, host genetic factors might play a critical role in 
determining susceptibility to S. aureus infections [104]. The pathogenicity of S. aureus is due 
to the ability of producing a repertoire of toxins, exoenzymes, adhesins, and immune-
modulating proteins [105, 106]. No single virulence factor has been proven to be sufficient to 
provoke a staphylococcal infection. Such infection is rather promoted by the coordinated 
action of various virulence factors, the expression of which is controlled by several regulatory 
systems [107-109]. Staphylococcal sepsis often begins from infected loci at the body surface 
such as skin and soft tissue infections, and induces an influx of neutrophils [110]. Tissue 
invasion and killing of phagocytes are involved in the inflammatory response that leads to 
septic shock [111]. In this model of infection, the kidney has been shown to be the main target 
organ [112]. Genetic control of immunity to S. aureus remains poorly understood, mostly 
because of the complex host-pathogen interactions that determine the outcome of infection. In 
this study, the intravenous infection model was used to evaluate MnSOD role as a potential 
host resistance factor.  
 
1.8  Listeria monocytogenes 
Listeria monocytogenes (L. monocytogenes, Lm) is a Gram+ intracellular bacterial pathogen 
causing disease in immunocompromised individuals and pregnant women [113]. Listeriosis 
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typically occurs after ingestion of L. monocytogenes in contaminated food, such as pre-
packaged meat and cheese [114, 115]. Infections by contaminated foods can cause 
gastroenteritis, meningitis, meningoencephalytis, and abortion [113]. Ingested Listeria 
reaches the large intestine, where InlA promotes listerial uptake into intestinal epithelial cells 
by targeting the adhesion molecule E-cadherin (hEC1) [116]. In case of systemic infection, 
bacteria enter the circulation and mainly target liver and spleen, where they infect hepatocytes 
and macrophages [117, 118]. Secondary infections are made possible by the second listerial 
invasion protein InlB which recognizes the HGF receptor, thus allowing access to several cell 
types [119-121].  
The lack of InlA-HGF interaction in mice is a major difference with humans, that led to the 
development of the intravenous infection model. This mouse model provides a good system to 
study innate and adaptive immune responses. Bacteria are internalized by the host cell into a 
phagosome, from which they escape by means of the expression of virulence factors. The 
bacteria further replicate into the cytosol and spread to neighboring cells without lysing the 
primary host cell. This intracellular life-cycle allows Listeria both to evade humoral defenses 
in the extracellular compartment and to escape the harsh environment of the phagosome.  
Both innate and adaptive immune responses are responsible for challenging L. monocytogenes 
infection [115]. Following infection with Lm, innate immune responses are rapidly triggered 
and are essential for host survival [122].  The effectiveness of innate immunity to L. 
monocytogenes was shown by studies using Severe Combined Immunodeficient (SCID) mice 
and nude mice (mice lacking the thymus and then deprived of mature T-cells) [85, 123]. Mice 
that lack both T-cell and humoral immunity were found to be remarkably resistant to infection 
with Lm at early time points, but were unable to control the infection in the long term. At the 
cellular level, neutrophils and macrophages are thought to be the principal mediators of the 
killing of Lm, and the depletion of granulocytes from mice markedly enhances their 
susceptibility to Lm infections [124]. Finally, in-vivo infections of p47
phox
 knock-out mice 
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emphasized the importance of the oxidative burst and the consequent production of ROS in 
the pathogen clearance: p47
phox
 is one of the sub-units composing the NADPH-oxidase 
complex, therefore the generation of ROS in response to infections is impaired in these 
knock-out animals, and the susceptibility to Lm challenge is increased [125]. In the present 
study, it was chosen to investigate the role of MnSOD during Listeria monocytogenes 
infections because of its differences to the two previously described infection models. 
Streptococcus pyogenes and Staphylococcus aureus are preferential extracellular pathogens. 
The characteristic life cycle of Listeria monocytogenes inside macrophages and the 
importance of ROS production in bacterial challenge make it an interesting target for our 
investigation about MnSOD as a host resistance genetic factor during infection.  
 
1.9  Conditional mouse mutants 
Conditional mutagenesis offers the possibility to knock out genes of specific cell types or at a 
specific point in time. Thus, the effects of gene loss in a cell type or at a certain 
developmental stage of the organism can be examined. This kind of mutagenesis employs the 
Cre-loxP system and the Flp-FRT system.  
Cre recombinase (causes recombination of the bacteriophage P1 genome) was originally 
isolated from the bacteriophage P1. Cre recombinase mediates the recombination between 
two loxP sequences [126]. The loxP sequence is an imperfect palindrome with two 13 bp 
inverted repeats, separated by an 8 bp non-palindromic sequence (spacer) [127]. The non-
palindromic portion gives the loxP an orientation. 
The recombinase-mediated deletion of the loxP-flanked region results in the loss of a plasmid 
containing the excised fragment and a single loxP site, while the other loxP is left on the 
genomic locus. This system has been proven to work very efficiently also in eukaryotic cells 
[128]. It can be used for deleting loxP-flanked genes or gene fragments[129] when the loxP 
Introduction 
22 
 
sequences are oriented in the same direction, or to induce the inversion of the floxed area, 
when the loxP orientation is opposite. 
 
 
 
 
Figure 2: Cre/loxP system in gene targeting. Cre/loxP system requires the presence of two loxP sites flanking 
a DNA segment of interest and expression of Cre-recombinase. (A) The loxP sites are introduced in vitro into a 
DNA segment, which is then targeted to the endogenous locus by homologous recombination in ES cells. (B) 
Deletion of the floxed DNA element is achieved in cells expressing Cre-recombinase. Cre-recombinase 
assembles at the loxP sites as a dimer (B) and induces recombination between loxP sites as a tetramer (C). (D) 
Upon successful excision of the floxed DNA sequence, the genomic sequence is irreversibly modified.  
     exons;  loxP sites;      cre-recombinase. Taken from [130]. 
 
Typical vectors for conditional mutagenesis contain (1) part of the target gene, with two 
homology regions upstream and downstream of the loxP sites, (2) two loxP sites placed in 
intronic regions, (3) the Neomycin gene as a selection marker which enables selection in 
bacteria and ES cells, and (4) a third loxP sequence or two FRT sequences that serve to delete 
the selection cassette after the identification of ES cells with homologous recombination. 
When using three loxP sequences, the selection marker is deleted by the Cre recombinase. 
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This implies the disadvantage that not only the selection marker, but also the floxed gene 
section may be deleted. Identifying clones with a correct deletion of the selection cassette is 
considerably time-consuming in this case. With Flp-recombinase and its specific recognition 
sequences (Flp recognition targets), the two deletion events can be induced separately [131]. 
Flp-recombinase and the matching FRT recognition sequences were isolated from 
Saccharomyces cerevisiae [132, 133]. Similarly to loxP sequences, FRT sequences consist of 
two 13 bp inverted repeats, separated by an 8 bp spacer. Consequently, the FRT sequences are 
directional as well, with two possible orientations.  
 
 
 
Figure 3: Conditional gene targeting. The gene cassette encoding Cre recombinase is usually engineered in a 
separate mouse strain. When Cre recombinase (red circle) is introduced, either as a transgene by crossing into a 
mouse line carrying the targeted gene locus or on a viral vector, the DNA between the loxP sites (red triangles) is 
removed, thereby inactivating the gene. Obtained from [134].  
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In the last decades, several transgenic mice containing the Cre recombinase gene downstream 
of cell-type specific or inducible promoters have been generated (the so-called Cre-lines). At 
present, the Cre-loxP system is mainly used for gene deletions, whereas the Flp-FRT system 
is used for deleting selection markers. Moreover, the deletion efficiency of the Flp-FRT 
system is lower than the Cre-loxP. Among the most important Cre lines used in 
immunological research, there are the CD19-Cre, CD4-Cre and LysM-Cre, in which the Cre 
recombinase is expressed downstream of promoters specific for B-cells, T-cells and 
Macrophages, respectively.  
With respect to mouse lines in which the Cre-recombinase expression can be induced in a 
time-specific fashion, Mx-Cre line relies on the Mx promoter, which is functional only in 
presence of interferon- : a single injection of interferon is sufficient to induce Cre and cause 
the deletion of the floxed fragment and subsequently to the inactivation of the gene. This 
thesis mainly employs LysM-Cre mice since macrophages and neutrophils, cells typically 
belonging to the innate immunity, play a major role in the analyzed infection models.  
 
1.10  Generation of targeting vectors using the ET cloning technique 
DNA modifications achieved through classical cloning techniques require restriction sites in a 
convenient position in order to do insertions and deletions and obtain a construct. The longer 
the construct, the more complicated the identification of unique restriction sites. This limits 
the possibilities for changing specific sections of a DNA.  
ET cloning or recombineering is a relatively new technique that enables systematic mutation 
of mammalian DNA carried in E. coli [135]. This technique is based on the ability of the Rac 
phage derived RecE and RecT [136-138] enzymes to promote homologous recombination of 
transformed DNA (i.e., PCR products carrying a mutated allele between the homology 
regions), with exogenous mammalian DNA carried extra-chromosomically in a vector or a 
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BAC (bacterial artificial chromosome). An equivalent system can be found in the -phage 
with the Red  and Red  enzymes. This system can be used for in vivo mutagenesis of E. coli 
as well [139]. 
RecE and Red  are 5’-3’ exonucleases [140], while RecT and Red  are proteins that bind 
single DNA strands. When both are present, they can mediate the overlapping of homologous 
DNA strands, transfer of single strands between different molecules, and strand inversion 
[136, 138]. The homologous recombination takes place more frequently when the DNA-
binding protein is expressed in excess [141]. Figure 4 shows the underlying mechanism of the 
homologous recombination. The 5’-3’ exonucleases RecE and Red , respectively, recognize 
double-strand breaks, as can be found in linearized DNA. They then digest the DNA strands 
at the 5’ ends. RecT and Red  can eventually bind to the resulting single strand protrusions, 
fostering the collocation of homologous strands, which leads to homologous recombination in 
the subsequent replication.  
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Figure 4: Red/ET Recombineering. The central step in Red/ET Recombineering is the crossover step between 
a targeting construct containing homology arms (hm) and the target which can be a gene locus on the E. coli 
chromosome or any other stretch of DNA in a BAC or plasmid vector. Obtained from www.genebridges.com.  
 
The ability of the in vivo recombination can be transferred to various E. coli strains by means 
of a plasmid that codes for the RecE and RecT enzymes. Commercially available plasmids 
(i.e., Genebridges) contain information for the expression of the recombination enzymes, 
under the control of a promoter inducible with L-arabinose.  
Due to the inducibility of the promoter, enzyme expression can be started at a designated time 
moment, thus avoiding unwanted recombination events. Moreover, plasmids have a 
temperature-sensitive replication starting point. This means that they will not be replicated at 
an incubation temperature of more than 30 C. At 37
o
C the plasmid will be progressively lost 
during cell division, avoiding any further unwanted recombination at the end of the 
recombination event. To enable the use of this method in all conventional E. coli strains, the 
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plasmids also contain the Red  gene. Red  encodes a -phage protein able to inactivate the E. 
coli RecBCD system [142, 143]. RecBCD is present in most of the E. coli strains and one of 
its purposes is to degrade linear DNA. Since ET cloning most often uses linear DNA in terms 
of PCR products, the activity of this enzyme complex has to be suppressed.  
ET cloning can be used for various applications. In this thesis, ET cloning was used to 
generate a conditional knock-out transfection plasmid. 
 
1.11  Research objectives 
The present study is centered on conditional gene inactivation. Both the generation and the 
phenotypical analysis  of conditional mouse mutants are described. The generation of 
conditional knock-out mice is an extremely time-consuming task, whose fulfillment can be 
negatively affected by several factors. Therefore, this thesis is divided into two parts: 
 
PART I. By using the ET cloning technique, previously established by Dr. Anne Fleige in the 
Experimental Immunology group at the Helmholtz Centre for Infection Research (HZI), we 
planned a strategy to modify the endogenous locus of the IL-12p40 murine gene contained in 
a BAC vector. This led to the creation of a targeting construct capable of recombining 
homologously within ES cells, which were subsequently injected into blastocysts in order to 
generate a conditional knock-out mouse line. In our knock-out strategy, we took into account 
the problems encountered in a previous PhD project concerning the creation of an IL-12p40 
conditional knock-out.  
 
PART II. Macrophage and neutrophil specific MnSOD knock-out mice were obtained 
through the breeding of MnSOD
fl/fl
 to LysM-Cre mice. First, the specificity of the gene 
deletion was evaluated. In order to investigate a possible involvement of MnSOD in the 
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protection of host organism components during bacterial challenge, in-vivo and in-vitro 
infections were performed. The three different bacteria used in the experiments were 
Streptococcus pyogenes, Staphylococcus aureus and Listeria monocytogenes. These were 
chosen in order to investigate various infection dynamics and kinetics. 
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2. Materials and Methods 
2.1 Generation of the floxed IL-12p40 mouse 
Mouse genomic DNA from a C57BL/6 bacterial artificial chromosome (BAC) clone 
containing the IL-12p40 gene in a pBACe3.6 vector (clone RP23-17E17 (RZPD) - 
www.ensembl.org -) was genetically modified using the ET cloning technique (Genebridges). 
First, a floxed Neo cassette carrying an additional EcoRI restriction site at the 3’ end was 
inserted into intron 6 using the BAC modification kit (Genebridges) according to 
manufacturer’s specifications.  
Initially, a PCR was performed on the PGK-neo-loxP plasmid (Genebridges) with the primers 
3’LOXs1 and 3’LOXas1 (for all primers, cf. Table 2). The deletion of the neo cassette was 
performed through transformation and induction of the PGK-Cre plasmid (Genebridges). 
Correct insertion was proved by PCR with the primers 3’LneoS1 (designed on the neo 
cassette) and 3’LneoAs1, resulting in a fragment of 1.1 Kbp only in the mutated sequence. 
The modified BAC was digested with BamHI. A 9 Kbp fragment containing the IL-12p40 
gene was ligated to a pBluescript vector (pBIISK+, Promega) previously digested with 
BamHI. Correct ligation was screened by restriction analysis and sequencing. Plasmids were 
digested with EcoRI and BamHI, and the ones showing the expected bands were further 
processed. Subsequently, the second loxP site, followed by a FRTmut-flanked Neo cassette, 
was inserted into intron 3 using the BAC modification kit. Since the loxP was not present in 
the plasmid containing the cassette, it was inserted through an appropriate primer design. The 
two primers used to amplify the FRT-PGK-gb2-neo-FRT plasmid (Genebridges) were 
5’LOXs1 and 5’LOXas1. Exploiting the presence of an EcoRI site in the FRTmut-flanked neo 
cassette, clones were screened for correct insertion by restriction analysis (BamHI and EcoRI 
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digestion). Sequencing of the mutated fragments was performed to further confirm successful 
and correct integration of the loxP sites and the additional Eco RI sites.  
The correct functioning of the loxP and FRTmut sites was assessed by transformation of the 
targeting construct into Cre- and Flp-expressing E. coli strains (Genebridges, 234-FLP and 
294-Cre, cat. # A101 and A111, respectively) and subsequent restriction analysis of the 
vector. 
The construct was digested and linearized with SacII and transfected into five different ES 
cell lines. Genomic DNA from the G418-resistant clones was extracted and analyzed by 
Southern Blot or PCR to assess the correct homologous recombination of the 5’ and the 3’ 
loxP sites, respectively. In the first case, DNA was digested with EcoRI, blotted on a 
membrane and hybridized with the probe IL12_5’: correct homologous recombination of the 
construct with the endogenous locus results in the detection of an 8.1 Kbp fragment, while the 
wt fragment’s length is 7.7 Kbp. In order to detect the presence of the 3’ loxP site at the 
correct site, and to avoid the amplification of fragments resulting from random recombination, 
the two primers for the PCR screening strategy, 3’LOXs1 and 3’WTas1, were designed on the 
loxP site and outside of the targeting construct homology region. The presence of a 1.5 Kbp 
fragment indicated successful integration. 
ES cell clones carrying the mutated allele were then injected into blastocysts. Subsequently, 
chimeric offspring was tested for germ-line transmission. 
 
2.2 Molecular biology techniques 
2.2.1 Chemicals 
Unless otherwise mentioned, all chemical products were purchased from Merck or Sigma-
Aldrich Chemical Company. 
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2.2.2 Restriction Enzymes 
All restriction analysis were performed with enzymes purchased from New England Biolabs 
together with their respective buffers, according to the manufacturer’s specifications. 
 
2.2.3 DNA isolation and gel purification 
Plasmid DNA isolation was performed using Nucleo Spin or Nucleobond AX 500 kits 
(Macherey-Nagel). The purification of DNA from agarose gel or PCR products was 
performed using the QIAGEN gel-extraction kit. 
 
2.2.4 Southern Blotting 
Digested DNA samples were loaded on a 0.8% agarose gel and run by electrophoresis at 50V. 
in TAE buffer (see section 2.7.2) until a 1 cm separation between the 10 Kb and the 8 kb 
marker was obtained. Subsequently, the gel was incubated for 15 minutes in a 0.25N HCl 
solution, followed by 15 minutes in a 0.4N NaOH. The DNA was then transferred on a 
positively charged Hybond XL membrane (Amersham) via the alkaline capillary blot method. 
 
2.2.5 Southern probe, radioactive labeling, and detection 
The IL12_5’ probe was generated by PCR and cloned into a TOPO4.0 vector (Invitrogen), 
and extracted by EcoRI digestion when needed. The probe consisted of a 750 bp DNA 
fragment obtained by PCR using the primers IL12_5’s and IL12_5’as, and wt ES cell DNA as 
a template. The suitability of the probe was corroborated by the absence of repetitive 
elements, as confirmed by the analysis with RepeatMasker (A.F.A. Smit, R. Hubley & P. 
Green RepeatMasker at http://repeatmasker.org) 
The efficiency of DNA cross-linking to the membrane was increased by one hour of 
incubation at 80
o
C following the blotting procedure. The membrane was equilibrated by 
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washing it in Church buffer at 60
o
C for one hour. Afterwards, it was prehybridized for at least 
two hours in QuickHyb (Stratagene) buffer at 65
o
C. Approximately 50 ng of the probe were 
labeled by PCR amplification with random primers and [α32P]-dCTP (Amersham Pharmacia 
Biotech) using the Ladderman Labeling Kit (Takara). After 45 minutes of incubation at 50
o
C, 
the PCR solution was purified on a centrifugation column (ProbeQuant
TM
 G-50 Micro 
Columns; Amersham). 100 µl of fish sperm DNA were added. The probe was denatured at 
95
o
C for five minutes and subsequently added to the prehybridization solution in which the 
membrane was incubated. The tube containing the membrane and the radioactive probe was 
incubated overnight in a rolling incubator at 65
o
C. On the following day, the membrane was 
washed twice for 20 minutes in Church buffer and then exposed overnight (O/N) to a 
Phosphoimager film. Radioactive emission of the film was acquired with the BASReader 3.14 
software. The images were analyzed with AIDA 3.51 (both programs purchased at Raytest 
Isotopenmessgeraete GmbH). 
 
2.2.6 Sequencing 
DNA fragments were amplified and cloned into a TOPO4.0 vector prior to sequencing, which 
was performed at the HZI sequencing facilities using the primers M13 forward and reverse 
(Biospring). 
 
2.2.7 Polymerase Chain Reaction (PCR) 
ET cloning fragments, Southern probes, and mouse genotyping were performed by PCR using 
Taq-Gold polymerase and buffers from Roche. Volumes varied between 20, 25, and 50 µl. 
Melting temperatures depended on the sequence and the specificity of the primers. Elongation 
time was chosen based on the length of the expected product. 
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2.3 Cell culture 
2.3.1 Murine embryonic stem (ES) cell lines 
IDG32.F1 (C57BL/6 x SW129) and C57BL/6-derived Bruce4 ES cell lines were kindly 
provided by Dr. Ralf Kühn (GSF, Munich). The IDG32.F1 cell line was chosen because of its 
high rate of homologous recombination. The 129/Ola-derived ES cell strain IB10 was 
provided by the lab of Prof. Dr. Klaus Rajewsky, University of Cologne. 
 
2.3.2 Murine embryonic feeder cells 
These cells constituted the layer upon which ES cells were allowed to grow. These cells carry 
a G418 (neomycin) resistance gene and were obtained from IL-10 knock-out mice. 
 
2.4 Media used in cell culture 
2.4.1 Medium for murine ES cell culture 
500 ml DMEM (glutamax, 4500 mg/l glucose, Na-pyruvate-free), 75 ml FCS (Gibco), 6 ml 
Na-pyruvate (Gibco), 6 ml penicillin/streptomycin (Gibco), 6 ml non-essential amino-acids 
(Gibco), 1.2 ml beta-mercaptoethanole (Gibco), and 1.2 ml Leukemia Inhibitory Factor (LIF; 
in-house production) were mixed under sterile conditions. When necessary, the medium was 
conditioned with 0.5 mg/ml G418 to enable screening of resistant clones.  
 
2.4.2 Freezing medium 
Prior to freezing, cells were re-suspended in a sterile filtered solution containing 50% FCS, 
30% ES cell medium (w/o G418), and 20 % DMSO.  
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2.5 Cell culture techniques 
2.5.1 Thawing of ES cells 
Tubes of ES cells were quickly thawed in a 37
o
C incubator and then recollected into a Falcon 
tube, washed with pre-warmed medium, and centrifuged at 200g for five minutes. The pellet 
was then re-suspended in the appropriate volume of medium and seeded on EF covered 
culture dishes (Nunc). 
 
2.5.2 Transfection of ES cells 
ES cells were grown on a 10 cm dish at 37°C and 5% CO2 until they reached approximately 
70% confluency. ES cells were then rinsed once with PBS. 2 ml of 1x trypsin/EDTA were 
added to the dish, followed by five minutes of incubation at 37°C in order to detach them 
from the plate. The reaction was stopped by adding 8 ml of ES cell medium. The cells were 
harvested, centrifuged and re-suspended in 1 ml of ES cell medium. Viable cells were counted 
using a Neubauer-counting chamber and approx. 1x10
7
 cells were transferred into an 
electroporation cuvette (Biorad) together with 10 µg of the linearized construct. 
Electroporation was set at 240 V and 475 mF using a Gene Pulser (Biorad). Afterwards, the 
cells were put at rest for 10 min. at room temperature (RT) and subsequently seeded onto 
feeder cells on 10 different Petri dishes. The medium was changed daily. After 48 to 72 hours 
(depending on the growth of the cells), the G418 selection was started at a concentration of 
0.5 mg/ml. This took seven to ten days. After antibiotic selection, G418-resistant clones were 
aspired and grown separately on a 96 well-plate (Nunc). 
 
2.5.3 Isolation of ES cell clones 
Clones integrating the neo cassette, in a random fashion or via homologous recombination, 
survived the G418 selection and grew as clones on the feeder cells layer covering the 10 cm 
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Petri dish. Plates were washed with PBS once and then re-filled with 10 ml of PBS. Individual 
ES cell clones were carefully removed in 10µl PBS using a 20µl Gilson pipette and then 
transferred to separate wells of a round bottom 96 well-plate containing 50µl 1X 
Trypsin/EDTA. After 20 minutes of  incubation, the wells were filled with 100µl of G418 
conditioned medium and subsequently split into three 96 well-plates. One of these plates was 
further expanded and split again in order to isolate a sufficient amount of DNA for PCR and 
Southern Blot analysis. The remaining two plates were stored at -80°C as master plates. The 
medium was changed daily. Gelatin-coated 96 well-plates were used for DNA isolation. 
 
2.5.4 Freezing of ES cell clones 
The two master plates were washed once with PBS and then incubated in 50µl 1X 
trypsin/EDTA per well for 5 min at 37°C. The reaction was stopped by adding 50µl ES 
medium. Afterwards, 100 µl freezing medium were added to each well. The plates were 
sealed with Parafilm and stored at -80°C to preserve them for further use. 
 
2.5.5 Isolation of genomic DNA from ES cells 
Cells were first lysed using proteinase K (Sigma) in tail buffer at 54°C overnight. On the 
following day, the plates were cooled at room temperature (RT) for 30 min and 100µl of 
100% ethanol were added in each well. The plates were incubated on a shaker for three hours 
at RT and then centrifuged at 3500g for 30 min at 4°C. The precipitated DNA was washed 
twice with 70% ethanol, dried at RT for 20 min, re-suspended in 30 µl TE buffer and finally 
incubated O/N at 54°C. A 1:10 dilution of each sample was used as a template for PCR 
screening. Digestion for Southern Blot analysis was achieved by adding 5µl 10X enzyme 
buffer, 0.5µl RNAse A (10 mg/ml; MBI Fermentas) and 50 U restriction enzyme, followed by 
O/N incubation at 37°C. 
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2.6 Bacterial strains  
2.6.1 E. coli strains  
DH5α chemocompetent bacteria were purchased from Invitrogen (cat. #: 12297016) 
 
2.6.2 Cre-expressing bacteria and flp-expressing bacteria  
E. coli 294-Cre and E. coli 294-Flp REF were purchased from Genebridges.  
 
2.6.3 Streptococcus pyogenes 
The group A streptococcus (GAS) KTL-3 strain was used in this study [98]. The stock 
cultures were stored in glycerole at -70
o
C and were subsequently cultured at 37
o
C in THY 
medium (see section 2.7.6). Bacteria were collected in mid-log growth phase, washed twice 
with sterile PBS, and diluted to the required inoculum. The number of viable bacteria was 
determined by counting colony forming units (CFUs) after diluting and plating on blood agar 
plates (Gibco) containing 5% sheep blood (Invitrogen, Karlsruhe).  
 
2.6.4 Staphylococcus aureus 
The SH1000 strain of S. aureus was used in this study [144]. Bacteria were grown to the 
stationary phase (15 h) at 37 ºC with shaking (125 rpm) in brain heart infusion (BHI)-
medium, collected by centrifugation for ten minutes at 3000 rpm, washed twice with sterile 
PBS, and adjusted to a concentration of 5 x 10
8 
CFU/ml. Aliquots of the S. aureus-suspension 
were frozen at –80°C for further use. The bacterial suspensions were diluted with PBS to the 
required concentration. The number of viable bacteria (CFU) was determined after serial 
diluting and plating on blood agar plates. 
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2.6.5 Listeria monocytogenes 
L. monocytogenes EGD (serotype 1/2a) stock cultures were maintained
 
at -70°C and cultured 
overnight on a BHI-agar plate at 37°C. A single colony was inoculated
 
in 5 ml of BHI broth 
and incubated overnight at 37°C. On the next day, the liquid
 
culture was diluted 1:10 in BHI 
and cultured until mid-log phase. Bacteria were washed with PBS. Viable bacteria were 
counted
 
using a Thoma chamber, and counting was confirmed by plating serial dilutions. 
 
2.7 Media and buffers  
2.7.1 LB Medium  
LB medium was used for culturing E. Coli, and LB-agar to pour agar plates. 10 g bacto-
tryptone, 5 g bacto-yeast extracts and 5 g NaCl were added to 950 ml of distilled water. The 
medium for LB-agar plates contained 15 g agar. The medium was conditioned with antibiotics 
at varying concentrations depending on whether the resistance was part of a high copy 
plasmid or a BAC: ampicillin at a final concentration of 100 mg/ml for high copy plasmid, 
and at 50 mg/ml for BACs; kanamycin at 50 mg/ml for high copy plasmids, and at 15 mg/ml 
for BACs; tetracyclin at 3 mg/ml for high copy plasmids; streptomycin at 50 mg/ml; and 
chloramphenicol at 15 mg/ml for BACs.  
 
2.7.2 TAE (50x) for gel electrophoresis  
242 g Tris, 57 ml 100% acetic acid and 100 ml 0.5 M EDTA with 1 l H2O.  
 
2.7.3 TE buffer  
10 mM Tris/HCl (pH 7.4) and 1 mM EDTA (pH 8.0). 
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2.7.4 Church buffer  
40 ml 1M NaHPO4 (pH 6.8) and 50 ml 20% SDS were mixed with H2O to give a 1:l solution.  
 
2.7.5 Tail buffer 
200 mM NaCl, 100 mM Tris/HCl (pH 8.5), 5 mM EDTA (pH 8.0) and 0.2% SDS. 
 
2.7.6 THY Medium 
Todd-Hewitt broth was purchased at Oxoid (cat. #: CM0189) and supplemented with 1% 
yeast extract. 
 
2.7.7 BHI medium 
Brain Heart Infusion (BHI) medium was purchased from Difco (cat. #:237200).  
 
2.8 Mouse strains 
The mice were kept under specific pathogen-free conditions at the Helmholtz Centre for 
Infection Research (HZI) animal facility. All animal experiments were conducted in 
accordance with institutional guidelines. All mice were bred and maintained at the HZI 
animal facility. 
B6;129P2-Lzm-s2
tm1(cre)Cgn 
(LysMCre) mice were on a pure B6 genetic background [145]. 
SOD2
flox
 mice were kindly provided by Prof. Dr. Scharffetter-Kochanek (University of Ulm, 
Germany) [146]. These mice were generated by the injection of 129/Ola ES cells into 
C57BL/6 (B6) blastocysts. Subsequently, mutant mice were backcrossed four times to B6 and 
further used for breeding and experiments. Due to the low number of backcrossings, these 
mice cannot be considered on a pure genetic background.  
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Breeding pairs were set up with MnSOD
fl/fl
 X MnSOD
fl/fl
LysMCre mice. Therefore the 
generated offspring was in any case homozygous for the MnSOD floxed allele. However, 
only 50% of the offspring carried the LysMCre recombinase gene. Animals carrying the 
recombinase and consequently the cell-type specific mutation, are referred to as conditional 
knock outs or LysMCre+ mice. Mice without the LysMCre recombinase are referred to as 
LysMCre-, and were used as wild type control. 
 
2.9 Isolation of genomic DNA from mouse tails 
The tip of a mouse tail was digested at 54°C overnight in 720μl tail-lysis buffer and 30μl 
proteinase K (10mg/ml). Cell debris and fur were separated by centrifugation at 13,000g for 
10min. The supernatant was transferred into a new reaction tube containing 600μl 
isopropanol. To precipitate the genomic DNA, tubes were agitated and centrifugation was 
performed for five minutes at 13,000xg. The harvested DNA was rinsed with 70% ethanol, 
dried at RT for about 10 min and finally dissolved TE-buffer. 
 
2.10 Mouse genotyping 
Mouse genotyping was achieved by PCR. The floxed allele was detected using the primer pair 
SOD2lox_s and SOD2lox_as (cf. Table 2), while Cre was detected with the primer pair 
cretot-1 and cretot2 (cf. Table 2).  
 
2.11 Cell sorting 
2.11.1 Isolation of cells from the spleen 
Mice were euthanized with CO2. The spleen was excised and homogenized using a cell 
strainer with pores of 100μm diameter (BD Falcon, cat. #: 352360). Cells were re-suspended 
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in 5 ml of PBS/BSA (0.2%) and stored on ice. After centrifugation at 250g, the cell pellet was 
incubated for 10 min at room temperature with 3 ml of lysing buffer (BD Pharm Lyse™, BD 
Biosciences Pharmingen) for erythrolysis. The suspension was filled up to 50 ml with 
PBS/BSA, centrifuged and the pellet re-suspended in 5 ml PBS/BSA. To determine the cell 
number, a dilution of 1/50 was counted in a Neubauer counting chamber. 
 
2.11.2 Antibodies staining for FACS analysis 
FACS (Fluorescence Activated Cell Sorting) was used to sort cells into different cell types 
using fluorescent labeled antibodies against surface molecules. Cells were sorted into CD19+ 
B-cells, CD4+ T-cells, and F4/80+ macrophages via  specific antibodies (cf. Table 1). An 
amount of 10x10
6
 cells was used for the staining. Propidium iodide (2mg/ml in 
PBS/0.1%BSA) was added to each sample prior to  sorting to discriminate between dead and 
living cells. Cell sorting was conducted with the MoFlo cell sorter (Cytomation). The purity 
of the sorted cell populations ranged between 90% and 99.9%. Sorting was performed both in 
LysMCre- and in LysMCre+ strains. Each group contained four animals. All of the mice were 
at least 15 weeks old. 
 
Table 1: Specification of antibodies 
Antigen Label Specificity Concentration Cat-No Supplier 
F4/80 FITC anti-mouse 0.1 mg/ml MCA497PE Serotec 
CD4 PE anti-mouse 0.2 mg/ml 553730 Becton 
Dickinson 
CD19 APC anti-mouse 0.2 mg/ml 550992 BD Biosciences 
Pharmingen 
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2.12 Bone marrow-derived macrophages and validation of the knock-out model 
Three MnSOD
fl/fl
LysMCre+ and three MnSOD
fl/fl
LysMCre- mice were sacrificed. Femurs 
were removed. Bone marrow was flushed out using 5 ml of cell culture medium (DMEM + 
10% FCS + 100 µg/ml Penicillin/Streptomycin). Bone marrow was filtered through a cell 
strainer and washed twice. The cell suspension was then plated in cell culture medium 
containing 50 ng/ml of M-CSF in order to induce the differentiation of stem cells and the 
adhesion of macrophages to the plate. Cells were plated O/N at 37
o
C and 5% CO2. After one 
day, the medium was changed, and M-CSF was added once again at the same concentration. 
The old supernatant was plated on a new Petri dish. At day four, medium was replaced with 
fresh one on both plates. On the seventh day after bone marrow extraction, differentiated 
macrophages were removed from the plate by incubation with 10 ml of 5 mM EDTA. DNA 
extraction was achieved through tail buffer and proteinase K O/N incubation, followed by 
isopropanole precipitation (see section 2.9). Subsequently, genomic DNA was digested with 
BamHI for Southern Blot analysis according to a previously described protocol [146]. The 
Southern probe was kindly provided by Nicolai Treiber (University of Ulm, Germany). The 
specificity and efficiency of the deletion in macrophages collected from the 
MnSOD
fl/fl
LysMCre+ mice versus MnSOD
fl/fl
Cre- mice was assessed by means of Southern 
Blot.  
 
2.13 In-vivo infections 
2.13.1 Streptococcus pyogenes (GAS KTL-3) infections 
Mice aged 6-9 weeks (16 LysMCre+ and 15 LysMCre-) were anesthetized via inhalation with 
Isofurane (Isoba, Essex Tierarznei) and infected subcutaneously with 5 X 10
7
 CFU of S. 
pyogenes KTL-3 in 100 µl of PBS at the right front flank in three independent experiments. 
Survival was checked twice a day. At day two, 10 µl of blood were sampled from the tail 
Materials and Methods 
42 
 
vein, and serial dilutions were plated on blood agar plates. Colony-forming units were 
counted after 24 hours of incubation at 37
o
C. 
 
2.13.2 Staphylococcus Aureus infections 
Mice aged 8-12 weeks were inoculated with 4 X 10
7
 CFU of S. aureus in 0.2 ml of PBS via a 
lateral tail vein. To determine the bacterial burden, infected mice were sacrificed by CO2 
asphyxiation at day one post-infection. The amount of bacteria was determined in the blood, 
liver, and kidney by preparing organ homogenates in 5 ml PBS and plating 10-fold serial 
dilutions on blood agar plates (kidney and liver), or by plating serial dilutions of blood 
collected directly from the heart. Bacteria colonies were counted after incubation for 24 hours 
at 37°C. Survival rates were checked once a day. 
 
2.13.3 In-vivo infection with Listeria monocytogenes 
Mice aged 10 to 14 weeks were injected via a lateral tail vein with two different amounts of 
bacteria, a sub-lethal dose (1 X 10
4
 CFU) and the LD50 (10
5
 CFU) respectively. In the 
experiment with a sub-lethal dose the body-weight was monitored daily. The LD50 injection 
was used to assess the survival rate, bacterial burden in liver and spleen (at day three post-
infection) and for histological analysis. 
 
2.14 Histology 
Two days post-infection, mice were sacrificed by CO2 asphyxiation. The peritoneal cavity 
was opened and the entire liver and spleen removed and fixed with 4% formalin for 48 hours. 
Tissues were processed and paraffin embedded using standard histological techniques. 
Sections were stained with H&E and were blindly scored for percentage of damaged tissue 
and neutrophil infiltration. 
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2.15 Cytokine assays 
Two days after intravenous Listeria monocytogenes (Lm) infection, mice were sacrificed by 
asphyxiation. Blood was collected directly from the heart. The samples were left for two 
hours at RT and then centrifuged 10 min. at 2500 rpm. The supernatant was collected and 
centrifuged again in order to purify sera. Serum samples were analyzed on a Luminex 100 
reader (Qiagen) using a mouse cytokine twenty-plex kit (Biosource), according to 
manufacturer’s specifications. 
 
2.16 Isolation and culturing of thioglycollate elicited peritoneal macrophages 
Mice were injected 1 ml of thioglycollate intraperitoneally in order to attract monocytes in the 
peritoneal cavity and activate macrophages [147]. Five days after the injection, mice were 
sacrificed by cervical dislocation and the skin was removed from the abdomen. Peritoneal 
exudates cells (PECs) were collected by injecting 10 ml of ice-cold PBS/FCS (1%) into the 
peritoneal cavity and then recollected into a Falcon tube. After a washing step in PBS/FCS, 
the pellet was re-suspended in 5 ml of ACK buffer and incubated for five minutes at RT, in 
order to allow erythrocyte-lysis. PECs were counted and aliquots of 3 X 10
5
 cells were plated 
on 24 well-plates (Nunc) and incubated O/N in cell culture medium. To  increase the 
activation state of macrophages and to enable them to challenge Lm infection, the medium 
contained 10U/ml of Interferon-γ (IFN-γ).  
 
2.17 In-vitro infection with Listeria monocytogenes 
Thioglycollate-elicited macrophages were used for in-vitro infection experiments to evaluate 
differences in the ability to challenge Listeria monocytogenes between MnSOD knock-out 
(LysMCre+) and wild-type macrophages (LysMCre-). Three different multiplicities of 
infection (MOIs) of Lm were used: 0.1, 1, and 5. After 16 hours of IFNγ stimulation, cells 
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were washed twice with PBS, and three different dilutions of a Lm liquid culture in the mid-
log growth-phase were put on top of the adherent cells. Plates were centrifuged 5 min. at 
150g, and then incubated 30 min. at 37
o
C, to allow bacterial uptake inside the phagocytes. 
Medium containing left-over bacteria was removed, the plate washed and gentamycin-
enriched medium was added to ensure the survival of Lm only inside phagocytes. 
Macrophages were incubated for 30 min, subsequently conditioned medium was removed and 
gentamycin-free medium added. Immediately after incubation in gentamycin conditioned 
medium, and after one and three hours, the concentration of Lm in the wells was determined 
as follows. Wells were washed once with PBS and 500 µl of lysis solution (0.5% Saponin in 
PBS) were added and incubated for 3 min. Aliquots of the lysis solution were serially diluted 
and plated on BHI-agar plates. Colonies were counted after 24 hours of incubation of the 
BHI-agar plates at 37
o
C, 5% CO2. Collected data were analyzed as CFU/well and were 
subsequently normalized to the average CFU at time 0 to evaluate the clearance ability 
regardless of the different uptake capacity. 
In order to determine the cytotoxic effect of the pathogen challenge on macrophages, LDH 
release was measured using the Cytotox96 kit (Promega, Germany, cat. #: G1780), according 
to manufacturer’s instructions. Briefly, 50 µl of the supernatant were collected at 0, 1,4, and 
24 hours after infection. Uninfected cells for each time point were used to measure lactate 
dehydrogenase (LDH) spontaneous release.  
 
2.18 Intraperitoneal Listeria monocytogenes infection and FACS 
Mice were injected 5 X 10
6
 CFUs of Lm intraperitoneally (i.p.). One hour after infection, 
PECs were collected as described in section 2.17. Cells were incubated for five minutes in 
erythrolysis buffer and then re-suspended in 3 ml of PBS/FCS (1%). 200 µl aliquots were 
transferred to a V-bottom 96 well-plate for further staining. First, FcγR was blocked by 5’ 
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incubation with CD16/32 antibodies (1:50 dilution). Cells were washed twice in Annexin-V 
Binding Buffer (BD bioscience). F4/80-FITC, CD11b-APC, and Annexin V-PE, were 
purchased at BD bioscience and titrated for optimal staining conditions, corresponding to 
1:200, 1:400, and 1:100 dilutions, respectively. Surface markers were stained by 30 min 
incubation at RT in Annexin-V buffer. After staining, cells were washed twice and re-
suspended in 300 µl of Annexin-V binding buffer. Propidium iodide (1:10.000) was added to 
the samples immediately before loading them into a FACS-CANTO (BD-Bioscience) 
apparatus.  
 
2.19 Primers  
All primers were purchased from Biospring (Frankfurt am Main, Germany) (cf. Table 2).  
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Table 2: PCR primers (All primers are represented in the 5’ 3’ orientation) 
Amplification of the PGKNeoLoxP plasmid  
3’LOXs1 GGCGCAACGCAATTAATG ATGGCGCAACGCAATTAATG 
3’LOXas1 AACTGATGGCGAGCTCAGACGAATTCAACTGATGGCGAGCTCAGAC
C 
First insertion checkup 
3’LneoS1 TTCATCGACTGTGGCCGGCT 
3’LneoAs1 TTAGTAAACTCCAACAGAAA 
Amplification of the FRTmut-flanked neomycin resistance gene (loxP site underlined) 
5’LOXs1 CTGTTTGCATCTTTTCTTGTTTCAATAACTTCGTATAGCATACATTA
TACGAAGTTATCTGCGATCGCCTAGGGGTAACC 
5’LOXas1 TGATTAGGAAGGGAAGACCTTGGAAAAGCTGGCGCGCCGTCGC 
Amplification of the Southern Blot probe IL12_5’ 
IL12_5’s AACTTGTCAAGGTCACATAAC 
IL12_5’as CATATAGTCAAGACAAGTACAAG 
MnSOD mice genotyping 
SOD2lox_s GCTGTCATTGCTTTTAACTGC 
SOD2lox_as TGCCAGATGTCACCTTAAAG 
Cretot1 ACGACCAAGTGACAGCAATG 
Cretot2 CTCGACCAGTTTAGTTACCC 
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PART I: Generation of the IL-12p40 conditional knock-out mouse 
3. Results for PART I 
3.1 Conditional targeting vector design 
The design of a good targeting vector is a crucial and probably the most difficult task for a 
successful strategy. IL12-p40 consists of 8 exons, and the gene sequence was obtained in the 
Ensemble genome database and analyzed with Vector NTI (Invitrogen) to establish which 
region of the gene should have been excised for an efficient knock-out. The latter is usually 
achieved via a frameshift creating early stop codons (often leading to digestion of the 
immature RNA), or by removing essential functional domains of the expressed protein. It was 
established that a deletion of the region including exons from 3 to 6 would efficiently 
inactivate the gene for the following reasons: (1) exons from 3 to 6 make up ¾ of the whole 
cDNA, and (2) due to the induced frameshift, only the first 31 of the remaining 78 amino 
acids possibly translated, remain intact. The rest of the amino acids are different due to the 
induced frameshift. Therefore, the two loxP were placed in intron 2 and intron 6 (cf. Figure 
5).  
Transfection of ES cells with a targeting vector very often results in a random integration of 
the construct, whereas homologous recombination occurs less frequently. 
The isolation of ES clones containing the construct was realized by adding a FRTmut-flanked 
neomycin cassette downstream of the loxP in intron 2, while discrimination between random 
versus homologous recombined clones was assessed by a Southern Blot and PCR strategy. 
Two EcoRI sites were inserted into the construct next to the loxP sites in order to create DNA 
fragments differing in length from the wild type, which were detectable with a labeled probe 
recognizing a region located outside of the targeting construct (cf. Figure 9). 
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Figure 5: Targeting strategy. Homologous recombination between the endogenous locus (top) and the 
targeting construct is rendered possible by the homology regions upstream of the 5’loxP and downstream of the 
3’loxP.  
 
 
3.2 Generation of the targeting vector 
Every ET cloning step was preceded by the transfection of the ET plasmid into E. coli cells 
carrying the BAC with the IL12-p40 gene. First, a Neo cassette flanked by two loxP sites and 
the additional EcoRI restriction site was inserted into intron 6. Correct insertion was proven 
by the growth of clones on Neomycin conditioned LB agar plates, followed by PCR analysis 
(cf. Figure 6).  
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Figure 6: LoxP-flanked neo cassette insertion. After the first ET-cloning step, five different BACs were 
isolated. Only BACs containing the cassette display a 1.1 Kbp band (lanes 2,3 and 5). 
 
 
Using primers within the Neo cassette and downstream of it, PCR amplification of the wt 
BAC sequence did not reveal any fragment, while the mutated locus showed a fragment of 1.1 
Kbp.  
A BAC portion of 9 Kbp containing the IL-12p40 gene was ligated to a pBSIISK+ vector, 
using the neomycin resistance for selection of transformed clones. Successful ligation was 
confirmed by sequencing.  
In the second ET cloning reaction, another loxP preceded by an EcoRI site and followed by an 
FRT-flanked Neo cassette was inserted into intron 2. Restriction analysis was performed with 
EcoRI in order to prove a 1:1 ligation (Figure 7). Vector NTI software predictions 
(Invitrogen), indicated the presence of 4 fragments deriving from EcoRI digestion, whose 
lengths are approximately 5.3 Kbp, 3.5 Kbp, 2.6 Kbp, and 700 bp (cf. Figure 7).  
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Figure 7: Restriction analysis of the targeting construct. Seven different plasmids were digested with EcoRI. 
Expected bands were observed in lanes 2, 3, 5, and 6. The seventh lane shows a control digestion of the targeting 
vector before the last insertion step was performed. Only plasmids shown in the fifth and in the sixth lanes were 
further processed.  
 
 
3.3 Analysis of the targeting vector 
Transfection plasmids showing the appropriate restriction patterns were further sequenced in 
HZI facilities. This confirmed the presence of the introduced elements. The plasmid was then 
transformed into E. coli strains expressing Cre and Flp recombinase to verify the correct 
function of the loxP and FRT sequences. After in vitro Cre-mediated deletion, the plasmid 
was digested with BamHI, leading to the expected products at 4.3 Kbp and 4 Kbp. (cf. Figure 
8). Similarly, after Flp-deletion the plasmids were digested with BamHI, leading to fragments 
of 8.1 Kbp and 4 Kbp (Figure 8). In both cases the length of the fragment was consistent with 
what expected by software simulation. 
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Figure 8: Restriction analysis subsequent to Cre and Flp mediated excisions. results in the loss of a 5.5 Kbp 
fragment . Digestion of the intact vector displays two bands at 9.8 Kbp and 3.9 Kbp (control). The 3.9 Kbp 
fragment is not affected by the recombinase-mediated deletions. After Cre-mediated deletion of a 5.5 Kbp 
fragment, a new band of 4.3 Kbp is present (upper right gel picture). Flp-mediated recombination results in the 
loss of a 1.7 Kbp fragment, as shown by the 8.1 Kbp band.  
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3.4 ES cells transfection and screening for homologous recombination 
10 µl of the targeting construct were linearized by SacII digestion and transfected into five 
different ES cell lines: IDG32.1 F1, IB101, BALB/c, Bruce4, and E14. A total of 
approximately 2500 clones were found to be G-418 resistant. These were then grown on 96 
well-plates to allow for DNA preparation and homologous recombination screening. The 
latter consisted of two strategies based on Southern Blot and PCR for the 5’ and the 3’ loxP, 
respectively. Only 5 out of the 2500 isolated clones showed the bands indicating for the wild 
type and the mutated allele (Figure 9).  
 
 
 
Figure 9: Southern Blot strategy. Hybridization of the probe with EcoRI-digested wt DNA (A) and mutated 
DNA (B), results in the detection of two fragments of different length (C).  
 
 
PCR was used to detect homologous recombination of the loxP contained in intron 6. By 
means of one primer matching on the loxP site and the other primer outside of the targeting 
vector homology region, a single clone (IL12cl17) carrying the correct mutation was 
identified among the five clones previously isolated. 
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Figure 10: PCR strategy for the detection of homologously recombined clones. Sense primer of the PCR 
screening (3’loxP2) is specifically annealing to the loxP sequence (A), whereas the antisense primer is located 
outside of the targeting construct homology region. Therefore, the presence of a 1.5 Kbp PCR product proves the 
presence of a homologously recombined clone (B).  
 
 
3.5 Injection of the positive clone into blastocysts 
IL12cl17 was expanded and injected into blastocysts of BALB/c mice. The injection resulted 
in the birth of 3 chimeras, which were bred with C57BL6 mice to be tested for germ-line 
transmission. Two of the three chimeras died, while the third one remained sterile. 
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4. Discussion of PART I 
4.1 DNA engineering using ET cloning 
The generation of the IL-12p40 conditional knock-out consisted of three phases: generation of 
the targeting construct, ES-cell transfection, and blastocysts injection of homologously 
recombined clones. Although the generation of the construct and the identification of 
homologously recombined clones were performed in a reasonable amount of time, no 
transgenic mouse was generated. ET cloning has previously been used in our group for the 
generation of two conditional knock-out targeting vectors . This method was chosen because 
it enables the manipulation of large DNA fragments, such as the IL-12p40 targeting construct 
described in the above chapter. Given the long distance between the loxP sites (5.5 Kbp) and 
the length of the homology regions (4.1 Kbp at the 5’ end, and 1.2 at the 3’), ET cloning 
allowed for the engineering of a large genomic region while avoiding the drawbacks of 
conventional cloning. Conventional cloning relies on restriction and ligation steps, and the 
ease of use depends on the frequency of restriction sites along the fragment of interest. 
Considering the length of the targeting vector (12 Kbp) and the lack of unique restriction 
sites, standard cloning techniques would have proven inconvenient. ET cloning, on the other 
hand, permits  homologous recombination in E. coli between a PCR-amplified fragment 
containing a 20 bp homology arm on each side and a target sequence. This procedure offered 
the right flexibility in choosing the insertion regions and in determining the length of the 
targeting construct homology arms.  
Although Genebridges states that a construct can be generated within three weeks, the 
generation of the construct took approximately six months. Compared to the time used 
previously by other members of our group to generate targeting vectors, there is a positive 
trend with respect to time-consumption. Nevertheless this time could be strongly reduced in 
several ways. First, all the PCR-amplified fragments used in the different recombination steps 
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could be generated in advance, thus saving time in the time intervals between the screenings 
and the transfections. Furthermore, optimization of the electroporation phase showed that the 
time to make the cells competent should be as quick as possible and the temperature kept low. 
Performing the washing steps in a cold room (4
o
C) and on ice improved the efficiency of the 
recombination. The use of a BAC (single copy vector) instead of a high copy plasmid also 
improves the time-consumption, since it avoids several purification and isolation steps. 
Moreover, integrations might be confirmed via appropriate PCR strategy instead of restriction 
analysis. Genebridges supplied our lab with a plasmid whose sequence differed from the 
version described in the manual. Thus, amplification of that particular plasmid was impaired. 
This turned out to be the main problem during the entire generation process. 
 
4.2 Transfection and screening 
Conditional gene targeting of the IL-12p40 locus had already been attempted in our group by 
Dr. A. Fleige [148]. The targeting vector she used had most of its features in common with 
the one described in the present thesis. The position of the loxP sites and the length of the 
homology arms was the same. The only substantial difference concerned the position of the 
FRT-flanked neo cassette, that in the first generated construct was placed downstream of the 
3’loxP site, whereas in the described construct is placed in intron 2. The above mentioned 
research project was unsuccessful because of the failure in the ES cell transfection step. This 
suggested that the presence of a large insert such as the Neo cassette (1.7 Kbp) next to the 
short homology arm impairs homologous recombination. Moreover, since intron 2 is 
approximately four times larger than intron 6 (5.4 Kbp vs 1.4 Kbp), placing the Neo cassette 
in intron 2 is less likely to have an effect on IL-12p40 expression in the absence of Cre-
recombinase. Homologous recombination in ES cells is a rare event and has been shown to be 
influenced by several parameters, such as the length of the homology regions, and the origin 
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of the ES cell line used for the transfection [23, 24, 149]. Only five clones out of 2500 G-418 
resistant ones had undergone homologous recombination at the 5’ end. These five clones all 
belonged to the Bruce4 ES cell line, a C57BL/6 derived cell line. The results of our targeting 
confirm previous observations of the BL/6 IL12p40 locus being the best for mutation 
purposes. This might be due to epigenetic factors such as chromatin rearrangement, which 
possibly allow access to the gene only in BL/6 derived ES cell lines. Taking into account only 
the Bruce4 transfection for the above mentioned reasons, the rate of correct homologous 
recombination is still very low (1 positive clone out of 430 = 0.23%). It could be argued that 
this is due to the short length of the 3’ arm of homology. Indeed, the latter allowed a high 
throughput transfection-screening strategy by PCR. Compared to Southern Blotting 
approaches, PCR results less expensive and time-consuming. However this is a minor gain 
and does not repay the loss in  homologous recombination efficiency. In the future it will be 
important to take into account that only C57BL/6 derived ES cells allow homologous 
recombination in the IL-12p40 locus, and a construct with longer homology arms should be 
generated. 
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PART II: Phenotypical analysis of macrophage and/or neutrophil specific MnSOD 
mouse mutants 
5 Results for Part II 
MnSOD conditional mouse mutants for macrophages and/or neutrophils were generated in 
order to investigate MnSOD involvement in bacterial infection models. Two groups of mice, 
MnSOD
fl/fl
LysMCre+ (LysMCre+, conditional knock-out group) and MnSOD
fl/fl
 (LysMCre-, 
control group), were infected with S. pyogenes, S. aureus, and L. monocytogenes in order to 
investigate the role of MnSOD expression in macrophages and neutrophils in the context of 
in-vivo and in-vitro infections. Prior to infection, the efficiency and specificity of LysMCre-
driven gene-deletion was evaluated by Southern Blot analysis.   
 
5.1 LysMCre efficiently catalyzes the excision of the floxed fragment in macrophages 
of LysMCre+ mice 
To examine whether LysMCre-driven deletion is specific and efficient, genomic DNA of bone 
marrow-derived macrophages (BMDM) was isolated from LysMCre+ and LysMCre- mice. 
Southern Blot analysis revealed good efficiency of the Cre-mediated deletions only in BMDM 
belonging to the LysMCre+ group (Figure 11), thus confirming the reliability of the Cre-loxP 
method for the inactivation of the MnSOD gene. The length of the “floxed” is approximately 
2.6 Kbp. When LysMCre deletion takes place, a BamHI restriction site is lost, the length of 
the recombined fragment increases up to 7.8 Kbp. The excision of the floxed fragment is not 
100% efficient, as shown by the presence of a light flox band at 2.6 Kbp in the LysMCre+ 
BMDM lane. This means that the excision of the floxed fragment catalyzed by LysMCre 
recombinase is efficient, and the MnSOD
fl/fl
 x LysMCre model is suitable for studying 
MnSOD deficiency in macrophages and/or neutrophils. 
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It has already been demonstrated that the excision of the third exon results in the inactivation 
of the gene product [150, 151]. Hence, the deletion showed in the picture implies the 
inactivation of the MnSOD gene. 
 
 
 
Figure 11: LysMCre-driven excision in LysMCre+ BMDM. DNA was extracted from macrophages isolated in 
wt, MnSOD
fl/fl
, and MnSOD
fl/fl
LysMCre+ mice. In the wt lane an 8.5 Kbp band is visible. The MnSOD fl/fl lane 
contains a single 2.6 Kbp band. In the Cre+ lane, the delta band (7.8 Kbp) is present, together with a flox band of 
very low intensity. 
 
T- and B-cells DNA from LysMCre+ and LysMCre- mice was isolated after cell-sorting. 
DNA digestion, electrophoresis, blotting, and hybridization with the radioactive probe were 
performed at the same conditions described for the DNA isolated from macrophages. 
However, no band was detectable in these samples. 
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5.2 Streptococcus pyogens infections 
5.2.1 MnSOD deficiency in macrophages and neutrophils does not influence 
susceptibility to GAS KTL-3 infection 
21 LysMCre+ and 20 LysMCre- mice were infected subcutaneously with 1 to 3 X 10
7
 CFU of 
GAS KTL-3 in four independent experiments. Mice health status was checked daily and 
survival curves were derived. Bacteremia was measured two days post-infection in blood 
samples collected from the tail.  
In the first experiment, LysMCre- mice were found to be more susceptible to the infection 
(Figure 12-A). Consistently with this finding, bacteremia in the LysMCre- group was higher 
than in the LysMCre+ group (Figure 13-A). Due to the low number of animals in the 
experimental groups, the difference was not statistically significant. In the second experiment, 
LysMCre+ mice were found to be more susceptible than the LysMCre- mice (Figure 12-B), 
and also bacterial levels in the blood were higher in the LysMCre+ group (Figure 13-B). In 
the third experiment, susceptibility to the infection was similar in the two experimental groups 
(cf. Figures 12-C and 13-C).  
In the fourth and last experiment, LysMCre- mice appeared once again more susceptible to the 
infection than LysMCre+ mice, although bacteremia levels measured in the two groups were 
substantially identical (cf. Figure 12-D and 13-D). Taken together, these results show no 
difference between LysMCre+ and LysMCre- mice in response to subcutaneous GAS KTL-3 
infections (cf. Figure 14). 
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Figure 12: Susceptibility to GAS-KTL-3 infections. Difference in susceptibility to GAS KTL-3 infections 
between LysMCre+ and LysMCre- mice was highly variable in four independent experiments. (A) 100% of 
LysMCre- mice died within four days after the infection, while 20% of LysMCre+ mice was able to challenge 
the infection and survive. (B) Contrary to the first experiments, GAS KTL-3 infection was lethal for all the 
LysMCre+ mice, whereas 20% of the LysMCre- survived the infection. (C) Similar survival trends between the 
two groups were find in the third experiment. (D) 60% of the LysMCre- group and 10% of the LysMCre+ group 
were able to survive the infection. None of the above mentioned differences was statistically significant.  
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Figure 13: Bacteremia. GAS KTL-3 CFU in blood samples collected from LysMCre+ and LysMCre- mice 
were similar in three out of four experiments (B-C-D). (A) bacteremia in LysMCre- mice was 10.000 times 
higher than LysMCre+ mice (** p<0.01) 
 
 
 
 
Figure 14: Cumulative results of GAS KTL-3 subcutaneous infection. (A) LysMCre+ and LysMCre- mice 
display no difference in susceptibility to GAS KTL-3 subcutaneous infection as evinced from the similar 
survival rate curves. (B) In both groups bacteremia ranges from 0 to 10
6
 CFU/ml of blood. No statistically 
significant difference is present between LysMCre+ and control mice. 
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5.3 Staphylococcus aureus infections 
Infections of several in-bred mouse strains with S. aureus showed that C57BL/6 mice are very 
efficient in controlling bacterial growth and clear the infection [144], leading to high survival 
rates. SW129 mice exhibit an intermediate phenotype, as they are not completely resistant to 
such infections ([144]). Hence, the mixed background of MnSOD
fl/fl
LysMCre mice was not 
expected to play a major role in this infection model, as in the case of S. pyogenes.  
 
5.3.1 Susceptibility to Staphilococcus aureus infection is not influenced by MnSOD 
expression in macrophages and neutrophils 
12 LysMCre+ and 10 LysMCre- mice were inoculated intravenously with 4 x 10
7
 CFU of S. 
aureus in 0.2 ml of PBS via a lateral tail vein. In both groups, mice started to die three days 
after infection, thus displaying an intermediate phenotype between C57BL/6 and SW129 
parental strains (Figure 11).  
 
 
 
Figure 15: Survival rate. S. aureus infection of LysMCre+ and LysMCre- mice results in similar survival rates. 
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LysMCre+ mice were slightly more susceptible to bacterial challenge, however this difference 
was not statistically significant.  
Bacterial levels in organs and blood were more clustered than in the streptococcal infections, 
suggesting a lower influence of the genetic background on the outcome of the infection with 
S. aureus. Nevertheless, no difference between LysMCre+ and control mice could be found 
(Figure 12). Taken together with survival rates, these results prove no major role for MnSOD 
over-expression as a protection factor in this infection model. 
 
 
 
Figure 16: Bacterial burden in blood, liver, and kidney homogenates. One day after S. aureus intravenous 
infection, there is no significant difference between MnSOD conditional knock-out mice and control mice.  
 
 
5.4 Listeria monocytogenes infections 
5.4.1 Sub-lethal infection 
A sub-lethal dose of L. monocytogenes was injected intravenously in order to assess the 
course of the infection with respect to the genetic background of the animals. The weight of 
the mice was measured before the infection (w0), and every day the percentage was calculated 
by dividing the registered weight by w0. Both groups displayed weight loss starting from day 
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two post-infection. Between day three and four, mice of the control group began to heal, 
while the LysMCre+ group mice displayed a drop in their health status at day four. At this 
time point, two mice from the LysMCre+ group died, and the recorded values decreased to 
10% of the original weight. The observed difference in weight loss between the two groups 
was statistically significant (Figure 13).  
 
 
Figure 17: Bodyweight analysis. After intravenous infection with Lm, LysMCre+ mice display a higher 
bodyweight loss along a time period of ten days. (***p<0.001) 
 
 
5.4.2 Survival experiments 
It has been shown that female mice are more susceptible to Listeria infections [99]. For this 
reason, male mice and female mice were infected in two independent experiments with 10
5
 
CFU of L. monocytogenes (male mice) and 4 x 10
4
 CFU (female mice). The amount of 
bacteria used for the intravenous infections corresponds approximately to the LD50 for the 
C57BL/6 strain. In both experiments, MnSOD conditional knock-out mice were significantly 
more susceptible to the infection than controls (Figure 14). In the experiment involving male 
animals and a higher bacterial inoculum, 50% of the control individuals died by day eight 
Phenotypical analysis of macrophage and/or neutrophil specific MnSOD mouse mutants - Results 
65 
 
post-infection and the remaining half recovered and survived until day 15, while all mice of 
the LysMCre+ group died by day seven. 
 
Figure 18: Listeria monocytogenes intravenous infections in female mice (left) and male mice (right). Both 
female and male LysMCre+ mice were significantly more susceptible than the sex-matched controls (p=0.0055 
and p<0.05, respectively).  
 
 
Combining the results obtained in sex-matched experiments, MnSOD
fl/fl
LysMCre+ mice were 
found to be significantly more susceptible to intravenous infection with L. monocytogenes 
than LysMCre- control mice (Figure 19).  
 
 
Figure 19 Cumulative survival rates results. Infection with a LD50 inoculum of Listeria monocytogenes was 
lethal for 100% of the LysMCre+ mice, whereas 65% of the control animals were able to challenge infection. 
This difference was statistically significant (***, p<0.001).  
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5.4.3 A higher Listeria monocytogenes burden is found in liver and spleen of 
conditional MnSOD knock-out compared to wild-type mice 
Liver and spleen are the main accumulation organs after systemic Listeria monocytogenes 
infection [119-121]. In the intravenous infection model, bacteria are directly released in the 
bloodstream, and two days after inoculation it is possible to evaluate the amount of bacteria 
infecting the organs. Bacterial burden in liver and spleen homogenates, as well as in blood 
samples, was measured in two independent experiments (cf. Figure 20). Five-fold higher 
levels of Lm were found in livers of LysMCre+ mice compared to the controls. Similarly, 
bacterial burden in spleens of MnSOD conditional knock-out mice was two times higher than 
in the controls. Both differences were statistically significant. No difference was found 
between blood samples. 
 
 
Figure 20: Organ burden two days after Lm infection. Higher amounts of bacteria were found in liver and 
spleen samples of LysMCre+ mice than in the controls. (***p<0.001; **p<0.01) 
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5.4.4 Conditional MnSOD deficiency influences Listeria monocytogenes induced 
damage in liver and spleen 
Liver and spleen are the main targets of Listeria monocytogenes after bacteria reach a 
systemic distribution. In the intravenous infection model, access to these organs takes place 
immediately after injection. Livers and spleens of mice infected with 2 x 10
5
 CFU were 
removed for histological analysis 48 hours after infection. H&E staining allows the detection 
of damaged tissue and mononuclear infiltration foci. Each slide was scored for percentage of 
damaged tissue. Livers of LysMCre+ mice presented severe multifocal mononuclear infiltrate, 
consisting of macrophages and few neutrophils (Figure 21-A). The number and dimensions of 
these inflammation foci was reduced in livers deriving from LysMCre- mice (Figure 21-B). 
Moreover, only in infiltrates of LysMCre+ mice livers it was possible to distinguish a central 
area of liquefying necrosis, revealing a higher damage and tissue disruption. 
Spleen sections from both groups displayed multifocal liquefying necrosis, recognizable by 
the disruption of the typical splenic tissue organization (Figure21-C D). In most cases, such 
formations were wider in spleens extracted from LysMCre+ mice. Spleen slides were scored 
on the percentage of necrotic tissue over the total area of the slide (Figure 22). Statistical 
analysis evidenced a significantly higher damage in liver slides of LysMCre+ mice. 
Difference in spleen scores was not statistically significant.  
The number and dimensions of these inflammation foci was reduced in livers deriving from 
control mice. Moreover, only in infiltrates of LysMCre+ mice livers it was possible to 
distinguish a central area of liquefying necrosis, revealing a higher damage and tissue 
disruption (Figure 21).  
 
 
Phenotypical analysis of macrophage and/or neutrophil specific MnSOD mouse mutants - Results 
68 
 
 
 
Figure 21: H&E staining of liver (A-B) and spleen (C-D) sections from Listeria monocytogenes infected 
mice at day two. Mononuclear cells infiltrates are larger in liver slides of LysMCre+ mice (A) than LysMCre- 
(B). A central area of liquefying necrosis is present in A, next to the blood vessel. C-D: typical organization of 
the splenic parenchyma is visible in the lower-left corner (dark purple). In the upper-right portion of the 
LysMCre+ spleen slide (C), a wide area of liquefying necrosis surrounded my macrophages is present. In the 
control slide (D), a smaller area is visible in the same portion of the slide.  = 200 µm. 
 
 
 
 
 
Figure 22: Spleen and liver histological score of LysMCre+ and LysMCre- mice. Both in the liver and the 
spleen slides, the percentage of damaged tissue is higher in LysMCre+ organs than in controls. This difference is 
statistically significant only in the liver slides. (*p<0.05) 
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5.4.5 MnSOD knock-out macrophages uptake higher amounts of bacteria and are 
impaired in challenging Listeria monocytogenes infections 
The ability of macrophages isolated from LysMCre+ and LysMCre- mice in challenging Lm 
infections was tested in two experiments with different multiplicity of infection (MOI). 
In the first experiment, 10
6
  cells were infected with approximately 10
5
 CFU of Lm 
(MOI=0.1). Infected cells were lysed after incubation with the pathogen (time 0), and after 
one and five hours. Bacterial uptake in MnSOD knock-out macrophages was ten times higher 
than in the wild-type (p<0.01, cf. Figure 23). One hour after infection, LysMCre- 
macrophages were able to clear the pathogen. On the contrary, MnSOD knock-out 
macrophages were able to reduce the bacterial burden after one hour but were unable to 
control the infection, as shown by the increase of CFU measured in the cells after five hours. 
Data normalized to the initial uptake confirmed that wild-type macrophages are more efficient 
in clearing the infection after one and five hours (cf. Figure 24). 
 
Figure 23: In-vitro macrophage infection with Listeria monocytogenes (MOI=0.1). Ten-fold higher uptake of 
Lm in LysMCre+ versus LysMCre- macrophages is shown at time 0. A higher amount of Lm CFU is found inside 
LysMCre+ cells compared to the control. (*** p<0.0005) 
 
In the second experiment 3x10
5
 macrophages were infected with 3x10
4
 CFU of Lm (MOI=1). 
The amount of bacteria surviving inside the cells was measured at zero, one, and three hours 
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post-infection. Bacterial uptake was three times higher in MnSOD knock out macrophages in 
comparison to wt macrophages (cf. Figure 25). 
 
 
Figure 24: Normalized CFU data (MOI=0.1). One and five hours post-infection, the percentage of uptaken 
bacteria still surviving inside phagocytes is significantly higher in LysMCre+ macrophages than in the control. 
(*p<0.05) 
 
Moreover, this experiment confirmed what was found in the first experiment, since the 
amount of bacteria inside LysMCre+ cells was higher than in LysMCre- macrophages at all 
time points. Nevertheless, wild type macrophages were not able to clear the infection as seen 
in the previous experiment with a lower MOI. Normalized data showed no significant 
difference at any time-point (cf. Figure 26). Both in LysMCre+ and in LysMCre- 
macrophages, there was a reduction of the bacterial load after one hour. In any case, after 
three hours the amount of CFU raised up to approximately 100% of the value measured 
immediately after the infection. Therefore, no significant difference was observed between the 
two groups in challenging the infection. 
Cytotoxicity caused by the pathogen was assessed in a third in-vitro infection experiment 
(MOI=5). Cell supernatants were analyzed for the presence of LDH (fold increase over 
uninfected) at zero, one, four, and 24 hours post-infection. Four hours after infection, wild 
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type macrophages were releasing significantly higher levels of LDH than the LysMCre+ (cf. 
Figure 27). After 24 hours, the cytotoxic effect measured in LysMCre+ cells was significantly 
higher than in the control.  
 
 
Figure 25: In-vitro macrophage infection with Listeria monocytogenes (MOI=1). Three-fold higher uptake of 
Lm in LysMCre+ versus control macrophages is shown at time 0. A higher amount of Lm CFU is found inside 
LysMCre+ cells compared to the LysMCre-. (** p<0.01) 
 
 
 
Figure 26: Normalized CFU data (MOI=1). LysMCre+ and LysMCre- macrophages show the same efficiency 
in challenging Lm infections 
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Figure 27: Cytotoxic effect of Lm in-vitro infection on macrophages. LDH release in LysMCre+ infected 
macrophages is significantly higher than in the wild-type. (** p<0.01) 
 
Taken together, these data showed a significant difference between LysMCre+ and LysMCre- 
macrophages in challenging Listeria monocytogenes infections: MnSOD knock-out 
macrophages were up-taking higher amounts of bacteria, which caused a higher cytotoxic 
damage and impaired bacterial clearance. 
 
5.4.6 Conditional MnSOD deficient mice produce higher levels of MCP-1 in response 
to Listeria monocytogenes infection 
Three days after intravenous infection with 10
5 
CFU of L. monocytogenes, serum samples 
were analyzed for cytokine and chemokine production with a Luminex kit. Surprisingly, no 
difference was found in pro-inflammatory cytokine levels between LysMCre+ and control 
mice. However, a three-fold higher concentration of MCP-1 was found in sera samples of 
LysMCre+ mice (cf. Figure 28). 
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Figure 28: Monocyte chemoattractant protein-1 (MCP-1) concentration in serum samples at day three 
post-infection. In response to the Listeria monocytogenes infection, higher amounts of MCP-1 are produced and 
released in the bloodstream of LysMCre+ mice than in controls. (**p<0.01) 
 
 
5.4.7 MnSOD does not influence the response to Listeria monocytogenes in the 
intraperitoneal infection model 
In order to investigate MnSOD role during Lm infection in the peritoneal cavity, LysMCre+ 
and LySMCre- mice were infected intraperitoneally and the PECs recollected one hour post-
infection. Collected cells were stained with F4/80-FITC, CD11b-APC, AnnexinV-PE and 
Propidium Iodide (PI). After FACS acquisition, macrophages were discriminated by the 
presence of the surface marker F4/80 or CD11b. The amount of dead cells was evaluated via 
Propidium Iodide (PI) and AnnexinV staining. Only cells which resulted F4/80 positive, 
AnnexinV negative and PI negative were counted as living macrophages (cf. Figure 29). All 
collected data were analyzed in terms of dead versus surviving macrophages. No significant 
difference was found between LysMCre+ and LysMCre- mice in this infection model.  
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Figure 29: FACS analysis of PECs in mice infected intraperitoneally with Lm. Examples of PECS analyzed 
via FACS from LysMCre+ (A) and LysMCre- (B) mice. The first gate (left) was set in order to include only cells 
in the analysis and get rid of cell debris. The second gate (centre) allows discrimination of macrophages (F4/80 
pos) from other cell-types. On the right, macrophages analysis is shown.  
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6. Discussion of PART II 
The aim of the second part of the present thesis was to investigate the involvement of MnSOD 
in host protection during infections. For this purpose, macrophage and/or neutrophil specific 
MnSOD knock-out mice were used for in-vivo infection models. Moreover, macrophages 
isolated from MnSOD conditional mutant mice were used for in-vitro experiments. Three 
different pathogens were used for the infections: Streptococcus pyogenes, Staphylococcus 
aureus, and Listeria monocytogenes. All of these bacteria are Gram+. Streptococcus pyogenes 
and Staphylococcus aureus are extracellular pathogens, while Listeria monocytogenes is 
intracellular.  
 
6.1 The MnSOD
fl/fl
LysMCre line is suitable for the generation of macrophage specific 
MnSOD knock-out mice 
Prior to infection experiments, efficiency and specificity of LysMCre deletion were evaluated. 
To this purpose, DNA was extracted from bone marrow derived macrophages (BMDM), T-
cells, and B-cells isolated from MnSOD
fl/fl
LysMCre+ (LysMCre+) and MnSOD
fl/fl
LysMCre- 
(LysMCre-), and the deletion assessed by Southern Blot analysis (see sections 2.11 and 2.12). 
The deletion proved to be efficient only in macrophages of the LysMCre+ line (see section 
5.1). Due to technical problems, it was not possible to show the presence of the “floxed” band 
in Southern Blot analysis of B-cells’ and T-cells’ DNA. B-cells and T-cells were isolated via 
cell-sorting, while macrophages were isolated and differentiated from the bone marrow. 
Southern Blot analysis was performed in two different experiments (one for BMDM, one for 
B- and T- cells). The conditions of DNA extraction, enzymatic digestion, electrophoretic run, 
blotting, and probe hybridization were the same in the two experiments. However, bands were 
present only in Southern blots of BMDM’s DNA. Hence, the substantial failure in showing 
the absence of the deletion in B- and T- cells is very likely due to the quality of the DNA. Due 
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to the lack of time, the experiment could not be further repeated. Nevertheless, the specific 
activation of the Lys-M promoter for macrophages and neutrophils has been already 
demonstrated [145, 152]. In the case of MnSOD gene, an ubiquitous inactivation can be 
excluded because the lethal phenotype resulting from the gene loss. For these reasons, the 
conditional knock-out model can be considered a valid instrument to investigate gene 
inactivation in macrophages and neutrophils. 
 
6.2 MnSOD does not play a major role in host defense against Streptococcus pyogenes 
KTL-3 infection 
Despite previous observation of MnSOD up-regulation during in-vitro infection of 
macrophages with Streptococcus pyogenes [89], no significant difference between MnSOD 
conditional knock-out mice and wild-type mice was found with respect to survival rates and 
bacteremia levels. Collected data showed an extremely high variance in both groups, with 
bacterial concentration in the blood ranging from 0 to 10
6
 CFU/ml. The same variance in 
susceptibility to the infection was observed during survival rate experiments, where mice 
from the same group were successfully challenging the infection and eventually surviving, 
while other mice were dying by day two post infection. As it has been previously mentioned, 
all mice used during the experiments were not on a pure genetic background (see section 2.8). 
When the experiments started to be performed the MnSOD
fl/fl
LysMCre breeding was supposed 
to be on a pure C57BL/6 genetic background. Nevertheless, after thorough examination of the 
back-cross breeding schemes, it was found that the number of backcrossing was not sufficient 
to guarantee a pure genetic background. Therefore, all mice of the above mentioned breeding 
were on a mixed genetic background, a random mosaic of SW129 and BL6 genes. SW129 
strain is very susceptible to Streptococcal infections, whereas C57BL/6 has an intermediate 
resistance compared to other inbred mouse strains [153]. The observed phenotype seems to be 
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due to host genetic factors, which may possibly overcome MnSOD effect. Therefore, MnSOD 
involvement in host protection against Streptococcus pyogenes cannot be excluded, however 
it does not seem to play a major role. The MnSOD
fl/fl
 line is currently under speed-congenics 
backcrossing, and the described experiments will be repeated on conditional MnSOD knock-
out mice on a pure C57BL/6 background as soon as the backcrossing will be ready. 
 
6.3 MnSOD expression does not affect susceptibility to Staphylococcus aureus 
infection 
Similarly to Streptococcus pyogenes, Staphylococcus aureus is an intracellular Gram+ 
bacterium. However, a mixed genetic background like the C57BL/6 - SW129 of the 
MnSOD
fl/f
 line was not believed to be influent on the S. aureus infection model because BL/6 
and SW129 mice were shown to have similar susceptibility to this pathogen [144]. In fact, 
both survival rates and bacteremia levels were much more similar within the experimental 
groups when compared to the outcome of streptococcal infections (see section 5.3). This 
infection model seems to be more solid in investigating MnSOD involvement during 
extracellular Gram+ bacterial challenge. Yet, LysMCre+ mice showed the same susceptibility 
displayed by LysMCre- mice, as inferred by the similar survival rates and bacterial burden in 
target organs such as liver and kidney.  
 
6.4 MnSOD deficiency in macrophages and/or neutrophils increases susceptibility to 
Listeria monocytogenes infection 
Survival rate of MnSOD conditional knock-out mice was significantly lower than wild-type 
mice (see section 5.4.2). Consistently with previous findings, about 70% of the wild-type 
animals were able to challenge the infections [99]. However, all the mice carrying the 
macrophage and/or neutrophil specific MnSOD gene mutation died within eight days after the 
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infection, indicating a major role of MnSOD expression as a host protective factor. In the Lm 
intravenous  infection model, bacteria rapidly disseminate in liver and spleen of the animal. 
The immune reaction is mainly carried on by resident macrophages and the attracted 
neutrophils [122]. In the early phase of infection, cells of the innate immune system  are 
responsible for controlling the infection and activating the adaptive immunity [122, 154]. A 
defective early response results in the presence of higher amounts of bacteria in these organs 
[155]. Similarly, in the present study high levels of Lm colonies were found in liver and 
spleen of infected animals 48 hours after the infection. However, the bacterial burden was 
significantly higher in LysMCre+ mice, thus suggesting that the incapability of controlling the 
infection in these organs might eventually lead to the observed lethal phenotype (see section 
5.4.3). Tissue damage was confirmed by hystopathological examination of liver and spleen 
sections. The hystopathological analysis of liver and spleen slides in this experiment was 
consistent with previous studies employing the EGD strain of Lm for intravenous infections 
[156].Such damage was significantly higher in LysMCre+ mice (see section 5.4.4). The 
observed lesions were larger and more severe in liver and spleen from MnSOD conditional 
knock-out, hence suggesting that organ failure is the cause of death. The link between 
uncontrolled bacterial growth and macrophage impaired functioning was provided by the in-
vitro experiments (see section 5.4.5). MnSOD knock-out macrophages were up-taking 
significantly higher amounts of bacteria, resulting in a decreased killing ability and in a higher 
cytotoxic effect. Moreover, cytokine and chemokine analysis in serum samples of infected 
animals showed the presence of significantly higher levels of monocyte chemoattractant 
protein -1 (MCP-1) in conditional knock-out mice than in wild-type animals. Higher 
production of MCP-1 in response to Lm infection by susceptible strains has been shown in 
several publications [155, 156]. In the described contest, the higher production of MCP-1 
could be interpreted as the attempt to recruit more monocytes to the site of infection because 
of a higher damage.  
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In conclusion, MnSOD expression protects macrophages in the context of Listeria 
monocytogenes infection. MnSOD deficiency decreases liver and spleen resident 
macrophages defensive functions. This leads to the observed tissue damage and eventually to 
death. 
 
6.5 Conclusion 
MnSOD is a mitochondrial antioxidant enzyme. Its function has been investigated 
predominantly with regard to aging, cardiovascular diseases, neurodegenerative disorders, 
drug toxicity, and cancer [157-161]. Most of these studies were performed on heterozygous 
Sod2+/- mice [162, 163]. To date, no involvement of MnSOD expression during infection has 
been reported. 
In the present study, the macrophage and/or neutrophil specific MnSOD knock-out line was 
analyzed with respect to the phenotype during infection. A novel protective role of MnSOD 
during bacterial infection was found. Notwithstanding its mitochondrial location, MnSOD 
deficiency led to an increased susceptibility to the intracellular Gram+ pathogen Listeria 
monocytogenes. Previous observations of MnSOD up-regulation in macrophages infected 
with Streptococcus pyogenes [89] led to the hypothesis of this study that MnSOD over-
expression might have a protective role during infection. While the findings concerning 
streptococcal infections cannot be interpreted due to the mixed genetic background (see 
section 6.3), the results obtained from an infection model with Staphylococcus aureus, 
another extracellular pathogen, did not support the hypothesized protective function of 
MnSOD. However, the fact that MnSOD was found to play a major role in host protection 
during Listeria monocytogenes suggests that the relevance of MnSOD may be specific for 
certain pathogens only. Although the findings from this study are not generalizable to any 
intra- or extracellular bacteria, they yield a preliminary insight into MnSOD protective 
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mechanisms. Considering that Listeria monocytogenes replication takes place inside 
macrophages, among other cell types [164], and the phagocyte-pathogen interaction is 
characterized by slower kinetics compared to staphylococcal challenge, it can be argued that 
the presence of MnSOD becomes more relevant during prolonged infection processes. In 
future research, it will certainly be interesting to investigate MnSOD involvement during 
parasitic infection. 
Finally, an improved understanding of MnSOD function during infections could be helpful for 
developing more efficient therapeutic strategies aimed at enhancing innate host defense 
mechanisms by fostering anti-oxidant activity, rather than targeting the pathogen alone.  
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Summary 
This thesis comprises two parts. The first part concerns the generation of an IL-12p40 
conditional knock-out mouse. ET cloning was employed to modify the endogenous locus of the IL-
12p40 murine gene contained in a BAC vector. The resulting targeting construct was capable 
of recombining homologously within ES cells, which were subsequently injected into 
blastocysts in order to generate a conditional knock-out mouse line. None of the generated 
chimeras could be tested for germ-line transmission due to early lethality and sterility.   
In part two, macrophage and/or neutrophil specific MnSOD knock-out mice were obtained 
through the breeding of MnSOD
fl/fl
 to LysM-Cre mice. Initially, the LysMCre-driven deletion 
of the loxP-flanked exon3 of MnSOD was shown to be specific and efficient. Subsequently, 
three different infection models, namely Streptococcus pyogenes, Staphylococcus aureus and 
Listeria monocytogenes, were tested in order to investigate the role of MnSOD during both 
extra-cellular and intra-cellular bacterial infections. The MnSOD
fl/fl
 x LysMCre breeding was 
not on a pure C57BL/6 genetic background. Thus, the results concerning the streptococcal 
infection model are not interpretable at this point. MnSOD deficiency was found to be 
irrelevant for the outcome of the infection during Staphylococcus aureus intravenous 
infections. However, a major protective role of MnSOD in Listeriosis models was established. 
Macrophage and/or neutrophil specific MnSOD knock-out mice displayed a significantly 
higher susceptibility to intravenous Listeria monocytogenes infection compared to controls, as 
implied by a lower survival rate and higher bacterial burden in liver and spleen. Moreover, in-
vitro experiments showed a higher bacterial up-take and a lower efficiency in killing bacteria.  
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